Sick Sinus Syndrome 2, Autosomal Dominant

🏷

Classifications

Harrison's Part

Channelopathy

👪

Inheritance

1

Autosomal dominant HP:0000006

SSS2 segregates as an autosomal dominant trait. All reported disease variants are heterozygous, and the dominant mechanism is usually dominant-negative suppression of wild-type HCN4 subunits within the heterotetrameric channel rather than simple haploinsufficiency. Penetrance and expressivity vary widely, from asymptomatic sinus bradycardia detected only on screening to syncope requiring pacemaker implantation.

Autosomal dominant inheritance

Show evidence (2 references)

PMID:17646576 SUPPORT Human Clinical

"Electrophysiological testing performed on 2 affected family members confirmed significant isolated sinus node dysfunction. Segregation analysis suggested autosomal-dominant inheritance."

Formal segregation analysis in a 16-member HCN4-G480R family established autosomal dominant transmission of isolated sinus node dysfunction.

PMID:12750403 SUPPORT In Vitro

"Coexpression experiments showed a dominant-negative effect of HCN4-573X subunits on wild-type subunits."

Co-expression of mutant with wild-type subunits demonstrates the dominant-negative mechanism underlying dominant transmission.

◈

Mechanistic Hypotheses

1

Sinoatrial Pacemaker Automaticity Failure Model (HCN4 specialization)

sinoatrial_automaticity_failure_model CANONICAL

Evidence balance 2 support

The disease-specific specialization of the module-level cardiac_ion_channel_repolarization group of the same name. In SSS2 the depressed current is specifically the hyperpolarization-activated funny current I_f carried by HCN4, so the bradyarrhythmia arises from a slowed diastolic depolarization slope in sinoatrial pacemaker cells rather than from depressed sodium-dependent conduction, and syncope follows from hypoperfusion during pauses rather than from ventricular tachyarrhythmia.

Pathograph links

HCN4 Loss-of-Function Variant -> Reduced Funny Current and Slowed Diastolic Depolarization DIRECT Reduced channel availability, a hyperpolarizing shift of the activation curve, or dominant-negative suppression of wild-type subunits lowers the inward diastolic current carried by I_f.

Reduced Funny Current and Slowed Diastolic Depolarization -> Sinoatrial Node Automaticity Failure DIRECT A slower diastolic depolarization slope lengthens the pacemaker cycle and depresses automaticity of the node as a whole.

Sinoatrial Node Automaticity Failure -> Syncope and Sudden Cardiac Death INDIRECT KNOWN INTERMEDIATES Severe bradycardia or a prolonged pause reduces cerebral perfusion, producing presyncope and syncope. Intermediates: prolonged sinus pauses and asystole; cerebral hypoperfusion

Show evidence (2 references)

PMID:16407510 SUPPORT In Vitro

"These changes, which mimic those of mild vagal stimulation, slow the heart rate by decreasing the inward diastolic current."

Names the funny-current-specific route to bradycardia that distinguishes this specialization from the sodium-channel arm of the module group.

PMID:26835093 SUPPORT Other

"All mutations described so far are loss-of-function and in agreement with the role of funny channels, the predominant type of arrhythmia found is bradycardia."

Confirms that the HCN4 arm of the model consistently yields bradyarrhythmia rather than tachyarrhythmia.

⚙

Pathophysiology

6

HCN4 Loss-of-Function Variant

A heterozygous loss-of-function variant in HCN4 alters the pore-forming subunit of the cardiac pacemaker channel. Reported disease alleles cluster in three structural regions with three corresponding biophysical consequences: pore-domain missense changes (G480R, G482R) that impair channel synthesis, trafficking, and gating; C-linker and cyclic-nucleotide-binding-domain changes (S672R, K530N) that shift activation gating; and C-terminal truncations (573X, 695X) that delete the cyclic-nucleotide-binding domain. All are heterozygous, and most act dominant-negatively on wild-type subunits within the heterotetramer.

Sinoatrial Pacemaker Automaticity Failure Model (HCN4 specialization)

cardiac pacemaker cell of sinoatrial node CL:1000477

HCN4 hgnc:16882

intracellularly cAMP-activated cation channel activity GO:0005222 ↓ DECREASED

sinoatrial node UBERON:0002351

Downstream

Reduced Funny Current and Slowed Diastolic Depolarization Reduced channel availability, a hyperpolarizing shift of the activation curve, or dominant-negative suppression of wild-type subunits lowers the inward diastolic current carried by I_f.

Loss of cAMP-Dependent Rate Modulation Truncations that remove the cyclic-nucleotide-binding domain, and C-linker changes that alter its coupling to the gate, uncouple the pacemaker current from cAMP.

Impaired Ventricular Trabecular Compaction In several pedigrees the same HCN4 allele co-segregates with left ventricular noncompaction, implicating the channel in myocardial development; the intermediate steps are not established.

Show evidence (3 references)

PMID:16407510 SUPPORT Human Clinical

"We found that sinus bradycardia in members of a large family was associated with a mutation in the gene coding for the pacemaker HCN4 ion channel."

The founding family study links a heterozygous HCN4 variant to inherited sinus bradycardia.

PMID:17646576 SUPPORT In Vitro

"Synthesis and expression of the wild-type and mutant HCN4 channel on the plasma membrane tested in human embryonic kidney 293 cells using biotinylation and Western blot analysis demonstrated a reduction in synthesis and a trafficking defect in mutant compared with wild-type channels."

Documents the synthesis/trafficking route to reduced channel availability for the pore-domain class of HCN4 alleles.

PMID:26835093 SUPPORT Other

"All mutations described so far are loss-of-function and in agreement with the role of funny channels, the predominant type of arrhythmia found is bradycardia."

Confirms that the HCN4 disease alleles reported to date are uniformly loss-of-function.

Reduced Funny Current and Slowed Diastolic Depolarization

The funny current I_f is the hyperpolarization-activated inward cation current that drives the early phase of spontaneous diastolic depolarization in sinoatrial node pacemaker cells. Mutant HCN4 channels activate at more negative voltages than wild-type channels, so at the diastolic potentials actually reached by a pacemaker cell less inward current flows. The diastolic depolarization slope falls, the interval to threshold lengthens, and the intrinsic firing rate of the node drops. The biophysical change has been described as mimicking mild vagal stimulation — a permanent, genetically imposed version of a physiological brake.

Sinoatrial Pacemaker Automaticity Failure Model (HCN4 specialization)

cardiac pacemaker cell of sinoatrial node CL:1000477

membrane depolarization during SA node cell action potential GO:0086046 ↓ DECREASED SA node cell action potential GO:0086015 ↓ DECREASED

sinoatrial node UBERON:0002351

Computational models

Fabbri-Severi human sinoatrial node cell model with HCN4 mutation-induced I_f changes PHYSIOLOGICAL The simulated beating rate of the human sinoatrial node cell model tracks the computed diastolic I_f charge very closely, and the same quantity correlates strongly with the resting and minimum heart rates observed in carriers of the corresponding HCN4 mutations.

Downstream

Sinoatrial Node Automaticity Failure A slower diastolic depolarization slope lengthens the pacemaker cycle and depresses automaticity of the node as a whole.

Show evidence (3 references)

PMID:12750403 SUPPORT Other

"The cardiac pacemaker current I(f) is a major determinant of diastolic depolarization in sinus nodal cells and has a key role in heartbeat generation."

Establishes the normal role of I_f in diastolic depolarization that is lost in SSS2.

PMID:16407510 SUPPORT In Vitro

"These changes, which mimic those of mild vagal stimulation, slow the heart rate by decreasing the inward diastolic current."

States the biophysical mechanism directly: less inward diastolic current slows the heart rate.

PMID:23178648 SUPPORT In Vitro

"In contrast, heteromeric channels composed of mutant and wild-type subunits displayed a significant hyperpolarizing shift in the half-maximal activation voltage."

Shows that the hyperpolarizing gating shift emerges specifically in heteromeric mutant/wild-type channels, the situation in a heterozygous carrier.

Loss of cAMP-Dependent Rate Modulation

Beta-adrenergic stimulation raises intracellular cAMP, which binds the cyclic-nucleotide-binding domain of HCN4 and shifts activation to more positive voltages, accelerating diastolic depolarization; vagal tone does the reverse. Truncating HCN4 alleles such as 573X delete this domain entirely, so the residual current is insensitive to cAMP. This is the proposed mechanistic basis of chronotropic incompetence in SSS2 — a failure of rate adaptation that is separable from the resting bradycardia. The corresponding mouse model shows that cAMP sensitivity of I_f sets basal and maximal heart rate while relative rate regulation during exercise is partially preserved by other mechanisms.

cardiac pacemaker cell of sinoatrial node CL:1000477

regulation of heart rate GO:0002027 ↓ DECREASED regulation of SA node cell action potential GO:0098907 ↓ DECREASED

Animal models

hHCN4-573X inducible cardiac transgenic mouse Mouse recapitulates Expression of the human disease allele eliminates cAMP sensitivity of I_f in sinoatrial node cells and lowers resting and maximal heart rate, the mechanism proposed for the human carrier.

Downstream

Chronotropic Incompetence Without cAMP-dependent acceleration of the pacemaker current, heart rate fails to rise appropriately with sympathetic drive.

Sinoatrial Node Automaticity Failure Loss of the cAMP-dependent positive shift lowers the operating range of pacemaker firing, compounding the resting depression of automaticity.

Show evidence (3 references)

PMID:12750403 SUPPORT In Vitro

"Patch-clamp experiments showed that HCN4-573X channels mediated I(f)-like currents that were insensitive to increased cellular cAMP levels."

Direct demonstration that a truncating HCN4 allele abolishes cAMP responsiveness of the pacemaker current.

PMID:12750403 SUPPORT Human Clinical

"Taken together, the clinical, genetic, and in vitro data provide a likely explanation for the patient's sinus bradycardia and the chronotropic incompetence."

Links the cAMP-insensitive channel phenotype to the patient's chronotropic incompetence.

PMID:19570998 SUPPORT Model Organism

"Our data demonstrate that cAMP-mediated regulation of I(f) determines basal and maximal heart rates but does not play an indispensable role in heart rate adaptation during physical activity."

A mouse model of the human 573X allele shows cAMP sensitivity of I_f sets basal and maximal rate; graded PARTIAL because it also shows relative exercise rate adaptation is preserved, qualifying the chronotropic claim.

Sinoatrial Node Automaticity Failure

Depressed pacemaker-cell firing translates into failure of the sinoatrial node to generate and deliver impulses at an appropriate rate: sinus bradycardia at rest, intermittent sinus pauses or arrest, and an inadequate rate response to demand. Because the node also anchors atrial activation, chronic bradycardia and the associated atrial electrical and structural remodeling raise susceptibility to atrial fibrillation, giving the tachycardia-bradycardia pattern that is unusually common in HCN4 carriers.

Sinoatrial Pacemaker Automaticity Failure Model (HCN4 specialization)

cardiac pacemaker cell of sinoatrial node CL:1000477

cardiac conduction GO:0061337 ↓ DECREASED regulation of heart rate by cardiac conduction GO:0086091 ↓ DECREASED

sinoatrial node UBERON:0002351

Animal models

Inducible cardiac-specific HCN4 knockout mouse (ciHCN4-KO) Mouse partially recapitulates Ablation reduces I_f and the spontaneous rate of isolated sinoatrial node myocytes and produces severe bradycardia in vivo, confirming that loss of HCN4 function is sufficient to depress nodal automaticity.

Downstream

Sinus Bradycardia Depressed nodal firing rate presents as resting sinus bradycardia.

Sinus Pauses and Sinus Arrest Intermittent failure of impulse formation produces sinus pauses and asystolic gaps.

Atrial Fibrillation Chronic bradycardia and atrial remodeling raise susceptibility to atrial fibrillation, producing tachycardia-bradycardia syndrome.

Syncope and Sudden Cardiac Death Severe bradycardia or a prolonged pause reduces cerebral perfusion, producing presyncope and syncope.

Show evidence (2 references)

PMID:17646576 SUPPORT Human Clinical

"Electrophysiological testing performed on 2 affected family members confirmed significant isolated sinus node dysfunction."

Invasive electrophysiology in HCN4-G480R carriers confirms isolated sinoatrial node dysfunction as the tissue-level lesion.

PMID:16407510 SUPPORT Human Clinical

"Thus, diminished function of pacemaker channels is linked to familial bradycardia."

States the causal chain from diminished pacemaker-channel function to the familial bradycardia phenotype.

Impaired Ventricular Trabecular Compaction

HCN4 is expressed during cardiac development, and in several independent pedigrees the same segregating HCN4 allele produces both bradycardia and left ventricular noncompaction — a myocardium with a persistently trabeculated, poorly compacted layer and deep intertrabecular recesses. This developmental arm is what distinguishes the HCN4 form of familial sick sinus syndrome from the sodium-channel forms, in which no structural abnormality is found. It is curated here as a parallel branch of the same genetic lesion rather than as maladaptive remodeling secondary to the arrhythmia: the noncompaction is present from childhood and does not follow a preceding phase of cardiomyocyte injury and neurohormonal activation. Some pedigrees additionally show dilation of the ascending aorta.

cardiac muscle cell CL:0000746

ventricular trabecula myocardium morphogenesis GO:0003222 ⚠ ABNORMAL

heart left ventricle UBERON:0002084

Downstream

Left Ventricular Noncompaction Failure of trabecular compaction gives the two-layered noncompacted myocardium seen on echocardiography and cardiac MRI.

Dilatation of the Ascending Aorta Ascending aortic dilation accompanies the noncompaction phenotype in some HCN4 families; the mechanism linking the channel to the aortic wall is unknown.

Show evidence (3 references)

PMID:25145517 SUPPORT Human Clinical

"One of these, p.Gly482Arg in HCN4, segregated with the combined bradycardia and LVNC phenotype in the entire family."

Establishes co-segregation of a single HCN4 allele with both the electrical and the structural phenotype.

PMID:25145517 SUPPORT Human Clinical

"Although mutations in HCN4 have been previously linked to bradycardia, our study provides the first evidence to our knowledge that mutations in this ion channel gene also may be associated with structural abnormalities of the myocardium."

States explicitly that HCN4 variants can produce a structural myocardial abnormality, not only an electrical one.

PMID:25145518 SUPPORT Human Clinical

"The symptom complex of SND and NCCM is associated with heritable HCN4 defects."

An independent German cohort reaches the same conclusion for the combined sinus-node/noncompaction phenotype.

Syncope and Sudden Cardiac Death

Severe bradycardia or a prolonged sinus pause transiently abolishes effective cardiac output, producing presyncope and syncope from cerebral hypoperfusion; an unterminated pause carries a risk of asystolic sudden death. This is the shared clinical endpoint with the other inherited arrhythmia syndromes, reached in SSS2 through bradyarrhythmia rather than ventricular tachyarrhythmia. Prognosis is variable and allele-dependent: the G480R pore-domain family remained asymptomatic with normal exercise capacity throughout long-term follow-up and required no pacemaker.

Show evidence (2 references)

PMID:34383451 SUPPORT Human Clinical

"About 50% of patients present with cerebral hypoperfusion (e.g., syncope, presyncope, lightheadedness, cerebrovascular accident)."

Supports cerebral hypoperfusion (syncope/presyncope) as the clinical endpoint of symptomatic sinus node dysfunction.

PMID:17646576 SUPPORT Human Clinical

"Despite its critical location, this mutation carries a favorable prognosis without the need for pacemaker implantation during long-term follow-up."

Qualifies the outcome node: at least one HCN4 pore-domain allele carries a benign long-term course, so the outcome is allele- and family-dependent.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

9

Cardiovascular 3

Atrial Fibrillation FREQUENT HP:0005110

Show evidence (2 references)

PMID:28104484 SUPPORT Human Clinical

"Moreover, HCN4 mutation carriers were more frequently associated with AF (43.8%) and LVNC (50%) and with older age at pacemaker implantation"

Quantifies atrial fibrillation at 43.8% of HCN4 mutation carriers, supporting the FREQUENT band (30-79%).

PMID:23178648 SUPPORT Human Clinical

"The index patient developed tachycardia-bradycardia syndrome and persistent atrial fibrillation (AF) in an age-dependent fashion. Pedigree analysis identified eight affected family members with a similar course of disease."

An HCN4 pedigree in which tachycardia-bradycardia syndrome with persistent atrial fibrillation is the segregating phenotype.

Syncope HP:0001279

Show evidence (1 reference)

PMID:34383451 SUPPORT Human Clinical

"About 50% of patients present with cerebral hypoperfusion (e.g., syncope, presyncope, lightheadedness, cerebrovascular accident)."

Syncope is a direct manifestation of the cerebral hypoperfusion caused by sinus node dysfunction.

Atrioventricular Block HP:0001678

Show evidence (1 reference)

PMID:26835093 SUPPORT Other

"Funny channel-linked arrhythmias, however, also include atrioventricular (AV) block and atrial fibrillation, in agreement with an emerging new concept according to which defective funny channels have a still unexplored role in impairing AV conduction and triggering atrial fibrillation."

A review places AV block in the HCN4 arrhythmia spectrum; graded PARTIAL because the review itself describes the AV-conduction role as an emerging and still unexplored concept.

Other 6

Sinus Bradycardia VERY_FREQUENT HP:0001688

Show evidence (2 references)

PMID:16407510 SUPPORT Human Clinical

"We found that sinus bradycardia in members of a large family was associated with a mutation in the gene coding for the pacemaker HCN4 ion channel."

Sinus bradycardia is the defining familial phenotype in the founding HCN4 pedigree.

PMID:35328031 SUPPORT Human Clinical

"Sinus bradycardia and dilation of the ascending aorta occurred in five studied patients."

Supports the VERY_FREQUENT band: sinus bradycardia was present in five of the six prospectively enrolled patients in this HCN4/LVNC series.

Sick Sinus Syndrome HP:0011704

Show evidence (1 reference)

PMID:28104484 SUPPORT Human Clinical

"SSS with HCN4 mutations may form a distinct SSS subgroup characterized by early clinical manifestation after adolescence and frequent association with AF and LVNC."

Defines HCN4-related disease as a distinct clinical subgroup of sick sinus syndrome.

Sinus Pauses and Sinus Arrest Abnormal electrophysiology of sinoatrial node origin HP:0011702

Show evidence (1 reference)

PMID:34383451 SUPPORT Human Clinical

"Electrocardiography findings include sinus bradycardia, sinus pauses or arrest, sinoatrial exit block, chronotropic incompetence, or alternating bradycardia and tachycardia (i.e., bradycardia-tachycardia syndrome)."

Sinus pauses and arrest are core electrocardiographic manifestations of sinus node dysfunction, the syndrome SSS2 produces.

Chronotropic Incompetence HP:0033992

Show evidence (2 references)

PMID:12750403 SUPPORT Human Clinical

"Taken together, the clinical, genetic, and in vitro data provide a likely explanation for the patient's sinus bradycardia and the chronotropic incompetence."

Documents chronotropic incompetence in the index HCN4-573X patient and attributes it to the cAMP-insensitive pacemaker channel.

PMID:17646576 REFUTE Human Clinical

"All affected family members were asymptomatic with normal exercise capacity during long-term follow-up."

Counter-evidence that chronotropic incompetence is not obligate in SSS2: the HCN4-G480R family retained normal exercise capacity.

Left Ventricular Noncompaction FREQUENT HP:0030682

Show evidence (2 references)

PMID:28104484 SUPPORT Human Clinical

"Moreover, HCN4 mutation carriers were more frequently associated with AF (43.8%) and LVNC (50%) and with older age at pacemaker implantation"

Quantifies left ventricular noncompaction at 50% of HCN4 mutation carriers, supporting the FREQUENT band (30-79%).

PMID:25145517 SUPPORT Human Clinical

"Subsequent screening of HCN4 in 3 additional families with the same clinical combination of bradycardia and LVNC identified HCN4 mutations in each."

Replication across three additional families establishes noncompaction as part of the HCN4 phenotype rather than a chance co-occurrence.

Dilatation of the Ascending Aorta Ascending tubular aorta aneurysm HP:0004970

Show evidence (1 reference)

PMID:35328031 SUPPORT Human Clinical

"The HCN4 molecular variants influence the presence of a complex LVNC phenotype, sinus bradycardia and dilation of the ascending aorta."

Reports ascending aortic dilation in HCN4 families. The HPO binding is exact rather than approximate — "Dilatation of ascending aorta" is an EXACT synonym of HP:0004970, and the source measured the ascending aorta in the parasternal long-axis view indexed to body surface area, the same segment the term names. Graded PARTIAL because the series is small (six patients, four families) and the mechanism linking the pacemaker channel to the aortic wall is unknown.

🧬

Genetic Associations

1

HCN4 loss-of-function variants (Causative)

Gene: HCN4 hgnc:16882 relationship_type: CAUSATIVE

Show evidence (2 references)

PMID:26835093 SUPPORT Other

"All mutations described so far are loss-of-function and in agreement with the role of funny channels, the predominant type of arrhythmia found is bradycardia."

Confirms the uniform loss-of-function direction of HCN4 disease alleles.

PMID:16407510 SUPPORT Human Clinical

"Thus, diminished function of pacemaker channels is linked to familial bradycardia."

States the gene-disease relationship established by the founding pedigree.

Variants (5)

HCN4 p.Ser672Arg

Gene: HCN4 hgnc:16882

Missense change near the cyclic-nucleotide-binding site, identified in a large familial sinus bradycardia pedigree. Mutant channels retain a normal response to cAMP but activate at more negative voltages than wild-type, reducing the inward diastolic current.

Show evidence (1 reference)

PMID:16407510 SUPPORT In Vitro

"The mutation associated with bradycardia is located near the cAMP-binding site; functional analysis found that mutant channels respond normally to cAMP but are activated at more negative voltages than are wild-type channels."

Characterizes the gating-shift mechanism of this allele.

HCN4 573X (c.1631delC)

Gene: HCN4 hgnc:16882

Heterozygous single-base deletion in exon 5 producing a C-terminally truncated subunit that lacks the cyclic-nucleotide-binding domain. Trafficking is normal, but the resulting current is cAMP-insensitive and the subunit exerts a dominant-negative effect on wild-type channels.

Show evidence (2 references)

PMID:12750403 SUPPORT Human Clinical

"In a candidate gene approach, a heterozygous 1-bp deletion (1631delC) in exon 5 of the human HCN4 gene was detected in a patient with idiopathic SND."

Identifies the truncating allele in the index patient with idiopathic sinus node dysfunction.

PMID:12750403 SUPPORT In Vitro

"The mutant HCN4 protein (HCN4-573X) had a truncated C-terminus and lacked the cyclic nucleotide-binding domain."

Establishes the structural basis for the loss of cAMP responsiveness.

HCN4 p.Gly480Arg

Gene: HCN4 hgnc:16882

Pore-domain missense change segregating with autosomal dominant isolated sinus node dysfunction in a 16-member family. Reduces channel synthesis and membrane trafficking and shifts activation to more negative voltages, yet carries a benign long-term course.

Show evidence (1 reference)

PMID:17646576 SUPPORT Human Clinical

"Direct sequencing of the exons encoding HCN4 revealed a missense mutation, G480R, in the ion channel pore domain in all affected family members."

Establishes complete co-segregation of the pore-domain allele with the affected status.

HCN4 p.Gly482Arg

Gene: HCN4 hgnc:16882

Pore-domain missense change segregating with the combined sinus node dysfunction and biventricular noncompaction phenotype. Mutant subunits are nonfunctional and dominant-negative on wild-type current.

Show evidence (1 reference)

PMID:25145518 SUPPORT In Vitro

"HCN4-G482R is located in the highly conserved channel pore domain. Mutant subunits were nonfunctional and exerted dominant-negative effects on wild-type current."

Characterizes the dominant-negative loss-of-function mechanism of this allele.

HCN4 p.Lys530Asn

Gene: HCN4 hgnc:16882

C-linker missense change identified by screening 422 patients with tachyarrhythmias. Homomeric mutant channels behave almost like wild-type; the loss of function appears only in heteromeric mutant/wild-type channels, which show a hyperpolarizing shift of half-maximal activation — the biophysical situation of a heterozygous carrier.

Show evidence (1 reference)

PMID:23178648 SUPPORT In Vitro

"In a candidate gene approach, we screened 422 patients with atrial and/or ventricular tachyarrhythmias and detected a novel HCN4 gene mutation that replaced the positively charged lysine 530 with an asparagine (HCN4-K530N) in a highly conserved region of the C-linker."

Identifies the C-linker allele and the screening context in which it was found.

💊

Medical Actions

4

Permanent Pacemaker Implantation

Action: pacemaker implantation Ontology label: Pacemaker Placement NCIT:C80434

Pacing is the definitive therapy for symptomatic bradycardia or symptomatic pauses; it does not correct the channel defect. In HCN4 carriers the age at implantation is later than in SCN5A-related familial sick sinus syndrome, and some HCN4 alleles never require a device. Chronotropic pharmacotherapy may defer but does not replace it.

Mechanism Target:

BYPASSES Sinoatrial Node Automaticity Failure — An implanted pacemaker substitutes an artificial impulse source for the failing sinoatrial node, bypassing rather than repairing the pacemaker current defect.

Show evidence (1 reference)

PMID:34383451 SUPPORT Human Clinical

"First-line treatment for patients with confirmed sinus node dysfunction is permanent pacemaker placement with atrial-based pacing and limited ventricular pacing when necessary."

Establishes pacing as the first-line intervention against the failing sinoatrial node.

Show evidence (2 references)

PMID:28104484 SUPPORT Human Clinical

"Moreover, HCN4 mutation carriers were more frequently associated with AF (43.8%) and LVNC (50%) and with older age at pacemaker implantation"

Reports age at pacemaker implantation specifically in HCN4 carriers, contrasted with the SCN5A form.

PMID:17646576 SUPPORT Human Clinical

"Despite its critical location, this mutation carries a favorable prognosis without the need for pacemaker implantation during long-term follow-up."

Counterpoint that pacing is not required for every HCN4 allele; graded PARTIAL because it qualifies rather than supports the indication.

Chronotropic Pharmacotherapy (Cilostazol)

Action: Pharmacotherapy NCIT:C15986

Agent: cilostazol CHEBI:31401

Cilostazol, a phosphodiesterase-3 inhibitor, raises heart rate in sinus node dysfunction and has been used to defer or avoid permanent pacing in symptomatic sick sinus syndrome. It is a rate-raising palliative acting downstream of the pacemaker-current defect rather than a correction of it, and the supporting evidence comes from unselected sick sinus syndrome cohorts, not from genotyped HCN4 carriers.

Mechanism Target:

MODULATES Sinoatrial Node Automaticity Failure — Cilostazol raises the sinus rate, partially offsetting the depressed nodal automaticity without restoring the funny current.

Show evidence (1 reference)

PMID:30982679 SUPPORT Human Clinical

"Cilostazol was effective for symptomatic SSS to avoid PM implantation by increasing HR."

Shows a rate-raising effect on the failing sinoatrial node. Graded PARTIAL because the cohort is unselected sick sinus syndrome rather than genotyped HCN4 carriers, so the mechanism link is inferred for SSS2.

Show evidence (2 references)

PMID:30982679 SUPPORT Human Clinical

"The 6-month PM implantation rate was lower in the cilostazol than the control group (20.4% vs. 55.8%, respectively; p<0.001)."

Quantifies the pacemaker-deferring effect. Graded PARTIAL because this is a single-centre retrospective case-control study in unselected sick sinus syndrome, not a randomized trial and not HCN4-genotyped.

PMID:33017571 SUPPORT Other

"This review summarizes the current knowledge about SND mechanisms and discusses the possibility of introducing new pharmacologic therapies for treating SND."

Frames pharmacologic management of sinoatrial node dysfunction as an area of active development rather than established practice; graded PARTIAL because it supports the existence of the therapeutic avenue, not the efficacy of any particular agent in SSS2.

Avoidance of Bradycardia-Inducing Medications

Action: supportive care Ontology label: Supportive Care NCIT:C15747

Because SSS2 carriers already run a reduced pacemaker current, drugs that further depress sinoatrial automaticity or conduction (beta-blockers, non-dihydropyridine calcium channel blockers, digoxin, and the selective I_f blocker ivabradine, whose molecular target is HCN4 itself) can unmask or worsen symptomatic bradycardia. Extrinsic contributors to sinus node dysfunction are frequently reversible, so medication review is part of management as well as of diagnosis.

Show evidence (2 references)

PMID:34383451 SUPPORT Human Clinical

"The causes of sinus node dysfunction are intrinsic (e.g., degenerative idiopathic fibrosis, cardiac remodeling) or extrinsic (e.g., medications, metabolic abnormalities) to the sinoatrial node."

Establishes medications as an extrinsic cause of sinus node dysfunction, which is the rationale for avoiding rate-slowing drugs in a carrier. Graded PARTIAL because the source addresses sinus node dysfunction generally and names no specific agent to avoid in HCN4 carriers.

PMID:34383451 SUPPORT Human Clinical

"A diagnosis is made by directly correlating symptoms with a bradyarrhythmia and eliminating potentially reversible extrinsic causes."

Supports elimination of reversible extrinsic causes, of which drug therapy is the main modifiable one; PARTIAL because the statement is framed as a diagnostic rather than therapeutic step.

Genetic Counseling and Cascade Family Screening

Action: genetic counseling Ontology label: Genetic Counseling NCIT:C15240

SSS2 is autosomal dominant with variable penetrance, so first-degree relatives of a proband carry a 50% prior risk and may be affected while entirely asymptomatic. Counselling plus cascade ECG, Holter, echocardiographic and HCN4 sequencing of relatives identifies those carriers, which matters here because the HCN4 phenotype includes a structural (noncompaction) arm that is not detected by rhythm assessment alone.

Show evidence (2 references)

PMID:17646576 SUPPORT Human Clinical

"Sixteen members of a family with sinus bradycardia were evaluated. Evaluation included a clinical questionnaire, 12-lead ECGs, Holter monitoring, echocardiography, and treadmill exercise testing."

Documents the family-wide evaluation protocol by which HCN4 relatives are screened, including the echocardiography needed to catch the structural arm.

PMID:17646576 SUPPORT Human Clinical

"Eight family members (5 males) were classified as affected. All affected family members were asymptomatic with normal exercise capacity during long-term follow-up."

Demonstrates the yield of cascade screening in SSS2: half the evaluated family was affected and every affected member was asymptomatic, so relatives would not have been identified without screening.

🔬

Diagnosis

3

Electrocardiography and ambulatory rhythm monitoring

Resting ECG and 24-hour Holter monitoring document the sinus bradycardia, sinus pauses, and bradycardia-tachycardia alternation, and correlate them with symptoms. Exercise testing assesses chronotropic response.

electrocardiography NCIT:C38053

Show evidence (1 reference)

PMID:34383451 SUPPORT Human Clinical

"Heart rate monitoring using electrocardiography or ambulatory cardiac event monitoring is performed based on the frequency of symptoms."

Establishes ECG and ambulatory monitoring as the diagnostic modality for sinus node dysfunction.

Cardiac imaging for noncompaction and aortic dimensions

Because the HCN4 form uniquely carries a structural arm, echocardiography and cardiac magnetic resonance are needed to look for left ventricular noncompaction, late gadolinium enhancement, and dilation of the ascending aorta in a carrier who presents only with bradycardia.

echocardiography NCIT:C16525

Show evidence (1 reference)

PMID:35328031 SUPPORT Human Clinical

"All six patients were diagnosed with LVNC by echocardiography, and five participants additionally by CMR."

Documents echocardiography and cardiac MRI as the modalities that detect the structural arm in HCN4 families.

Genetic testing of HCN4

Targeted or panel sequencing of HCN4 confirms the diagnosis in a proband with familial or early-onset sinus node dysfunction, particularly when bradycardia is accompanied by noncompaction, and enables cascade screening of relatives, many of whom are asymptomatic.

genetic testing NCIT:C15709

Show evidence (1 reference)

PMID:25145518 SUPPORT Human Clinical

"Targeted next-generation and direct sequencing were used for candidate gene analysis and mutation scanning."

Describes the sequencing approach used to establish the HCN4 diagnosis in families with the combined phenotype.

🔀

Differential Diagnoses

5

Conditions with similar clinical presentations that must be differentiated from Sick Sinus Syndrome 2, Autosomal Dominant:

Familial Sick Sinus Syndrome MONDO:0012061

Overlapping Features The dismech umbrella entry for inherited sinoatrial node dysfunction, which spans several causal genes (HCN4, SCN5A, ANK2, LMNA) and both dominant and recessive transmission. SSS2 is the HCN4-specific, autosomal dominant member of that set and is curated separately because MONDO models it as a distinct disease-series-by-gene entity with its own OMIM record.

Distinguishing Features

The umbrella entry is gene-heterogeneous and also spans the autosomal recessive SCN5A form, LMNA and ANK2.
SSS2 is defined by a heterozygous HCN4 loss-of-function variant acting on the funny current.
Left ventricular noncompaction is a characteristic co-segregating feature of the HCN4 form specifically.

Sick sinus syndrome 1 Not Yet Curated MONDO:0024562

Overlapping Features The SCN5A-related form of familial sick sinus syndrome, in which compound-heterozygous loss-of-function alleles of the cardiac sodium channel reduce myocardial excitability.

Distinguishing Features

Recessive rather than dominant transmission.
Markedly younger age at diagnosis and at pacemaker implantation than the HCN4 form.
Lacks the atrial fibrillation and left ventricular noncompaction burden characteristic of SSS2.

Show evidence (1 reference)

PMID:28104484 SUPPORT Human Clinical

"Meta-analysis of HCN4 mutation carriers showed a significantly younger age at diagnosis"

Establishes the age-at-diagnosis separation between HCN4 (SSS2), sporadic sick sinus syndrome, and SCN5A (SSS1) carriers.

Sinoatrial Block MONDO:0020806

Overlapping Features Failure of conduction of the sinoatrial impulse out of the node into atrial myocardium, producing pauses that on the surface ECG can look like sinus arrest.

Distinguishing Features

Sinoatrial block is a disorder of impulse exit (conduction); SSS2 is a disorder of impulse generation (automaticity).
Sinoatrial exit block may also occur within the SSS2 phenotype, so the distinction is mechanistic rather than mutually exclusive.

Sinoatrial Node Dysfunction and Deafness MONDO:0013960

Overlapping Features An autosomal recessive channelopathy caused by biallelic CACNA1D loss-of-function, in which loss of the Cav1.3 L-type calcium current produces both sinoatrial node dysfunction and congenital deafness.

Distinguishing Features

Recessive CACNA1D rather than dominant HCN4.
The calcium-current lesion is shared with the cochlear inner hair cell ribbon synapse, so congenital sensorineural deafness accompanies the bradycardia.
No left ventricular noncompaction.

Sick sinus syndrome 4 Not Yet Curated MONDO:0859173

Overlapping Features Familial sinus node and atrioventricular conduction dysfunction caused by variation in the G-protein subunit gene GNB2.

Distinguishing Features

The lesion is in G-protein signalling upstream of the pacemaker channels rather than in the channel itself.
Atrioventricular conduction disease is a defining rather than incidental component.

🐁

Animal Models

2

hHCN4-573X inducible cardiac transgenic mouse

Mice engineered for heart-specific, inducible expression of the human truncating HCN4-573X allele found in the index SSS2 patient. The model isolates the cAMP-insensitivity arm of the human mechanism.

Species

Mouse

Genotype

heart-specific, inducible expression of the human HCN4-573X allele

Publication

PMID:19570998

Pathograph links

Loss of cAMP-Dependent Rate Modulation recapitulates fidelity: high Expression of the human disease allele eliminates cAMP sensitivity of I_f in sinoatrial node cells and lowers resting and maximal heart rate, the mechanism proposed for the human carrier.

Limitations: The transgene is expressed heart-wide and inducibly rather than as a germline heterozygous allele, and murine sinoatrial physiology operates at a resting rate roughly an order of magnitude faster than human. The model also shows that relative rate adaptation during exercise is preserved, so it does not reproduce chronotropic incompetence as completely as the human case report implies.

Readouts

cAMP sensitivity of I_f in sinoatrial node pacemaker cells

Direction: ABOLISHED

Interpretation: Direct molecular readout of the proposed human mechanism.

Show evidence (1 reference)

PMID:19570998 SUPPORT Model Organism

"We found that hHCN4-573X expression causes elimination of the cAMP sensitivity of I(f) and decreases the maximum firing rates of SAN pacemaker cells."

Reports elimination of cAMP sensitivity and reduced maximal pacemaker firing rate.

Heart rate in conscious mice at rest and during exercise

Direction: DECREASED

Interpretation: Whole-animal correlate of the human resting bradycardia and blunted maximal rate.

Show evidence (1 reference)

PMID:19570998 SUPPORT Model Organism

"In conscious mice, hHCN4-573X expression leads to a marked reduction in heart rate at rest and during exercise."

Direct in vivo measurement of the bradycardic phenotype.

Show evidence (1 reference)

PMID:19570998 SUPPORT Model Organism

"Our data also reveal the pathophysiologic mechanism of hHCN4-573X-linked SAN dysfunction in humans."

The authors state explicitly that the model is informative for the human HCN4-573X sinoatrial node dysfunction mechanism.

Inducible cardiac-specific HCN4 knockout mouse (ciHCN4-KO)

Adult-onset, cardiac-specific ablation of Hcn4, which removes rather than alters the pacemaker channel. Establishes that HCN4 is required for normal impulse generation in the adult heart.

Species

Mouse

Genotype

inducible, cardiac-specific Hcn4 ablation in the adult

Publication

PMID:21220308

Pathograph links

Sinoatrial Node Automaticity Failure partially recapitulates fidelity: moderate Ablation reduces I_f and the spontaneous rate of isolated sinoatrial node myocytes and produces severe bradycardia in vivo, confirming that loss of HCN4 function is sufficient to depress nodal automaticity.

Limitations: Complete ablation of both alleles in the adult heart is a far more severe lesion than the heterozygous, partially functional channels of human SSS2: the mice progress to atrioventricular block, cardiac arrest and death within days, an outcome not seen in HCN4 carriers, so the model overstates severity and adds an AV-conduction phenotype not characteristic of the human disease.

Readouts

HCN4 protein expression in sinoatrial node tissue and cells

Direction: DECREASED

Interpretation: Confirms the molecular lesion underlying the depressed nodal automaticity measured in the same animals.

Show evidence (1 reference)

PMID:21220308 SUPPORT Model Organism

"In agreement with functional results, immunofluorescence and Western blot analysis showed reduced expression of HCN4 protein in SAN tissue and cells."

Confirms loss of HCN4 protein in sinoatrial node tissue accompanying the functional deficit.

Show evidence (1 reference)

PMID:21220308 SUPPORT Model Organism

"Our data show that cardiac HCN4 channels are essential for normal heart impulse generation and conduction in adult mice and support the notion that dysfunctional HCN4 channels can be a direct cause of rhythm disorders."

States that the model supports dysfunctional HCN4 channels as a direct cause of rhythm disorders, the claim this entry makes for SSS2.

🧮

Computational Models

1

Fabbri-Severi human sinoatrial node cell model with HCN4 mutation-induced I_f changes PHYSIOLOGICAL

A published in-silico risk-stratification study of SSS2. In-vitro biophysical data for HCN4 loss-of-function alleles were used to compute the charge carried by I_f during diastolic depolarization of a prerecorded human sinoatrial node action potential, and that quantity was used to drive the Fabbri-Severi model of a human sinoatrial node pacemaker cell. It is the computational counterpart of the funny-current node in this entry: it makes the qualitative claim (less diastolic I_f, slower firing) quantitative and allele-specific.

PMID:37760888

Pathograph links

Reduced Funny Current and Slowed Diastolic Depolarization measures fidelity: moderate The simulated beating rate of the human sinoatrial node cell model tracks the computed diastolic I_f charge very closely, and the same quantity correlates strongly with the resting and minimum heart rates observed in carriers of the corresponding HCN4 mutations.

Limitations: The correlation with clinical heart rate is strong but not deterministic, the analysis is restricted to the subset of HCN4 alleles with both quantitative clinical and in-vitro data, and the authors state that a translational perspective remains to be established.

Show evidence (1 reference)

PMID:37760888 SUPPORT Computational

"The clinically observed minimum or resting heart rates showed a strong correlation with Qf"

Links the simulated diastolic funny-current charge to the heart rate actually measured in HCN4 mutation carriers.

Findings

The diastolic funny-current charge computed by action-potential clamp predicts both the simulated pacemaker rate of a human sinoatrial node cell model and the resting or minimum heart rate of HCN4 mutation carriers, making it a candidate risk-stratification measure for HCN4 loss-of-function sinus bradycardia.

Show evidence (1 reference)

PMID:37760888 SUPPORT Computational

"The beating rate of the model cell showed a very strong correlation with Qf from the simulated action potential clamp experiments"

Reports the correlation between simulated pacemaker rate and diastolic funny-current charge that this finding states.

Show evidence (1 reference)

PMID:37760888 SUPPORT Computational

"HCN4 is the gene responsible for the hyperpolarization-activated 'funny' current If, which is an important modulator of the spontaneous diastolic depolarization underlying the sinus node pacemaker activity."

States the mechanistic premise the simulation encodes, matching this entry's funny-current pathophysiology node.

{ }

Source YAML

click to show

name: Sick Sinus Syndrome 2, Autosomal Dominant
creation_date: "2026-08-17T00:00:00Z"
category: Mendelian
description: >-
  Sick sinus syndrome 2 (SSS2) is the autosomal dominant, HCN4-related form of
  familial sinus node dysfunction. HCN4 encodes the pore-forming subunit of the
  hyperpolarization-activated, cyclic-nucleotide-gated pacemaker channel that
  carries the funny current (I_f), the inward current responsible for the early
  phase of diastolic depolarization in sinoatrial node pacemaker cells and for
  the cAMP-dependent autonomic modulation of heart rate. Heterozygous
  loss-of-function variants act either by shifting the voltage dependence of
  activation to more negative potentials, by dominant-negative suppression of
  wild-type subunits, by defective channel synthesis and trafficking, or by
  truncating the cyclic-nucleotide-binding domain so that the channel becomes
  cAMP-insensitive. The result is a smaller inward diastolic current, a slower
  rate of diastolic depolarization, and depressed sinoatrial automaticity —
  clinically, sinus bradycardia, sinus pauses, chronotropic incompetence,
  syncope, and a high burden of atrial fibrillation. A distinctive feature of
  the HCN4 form, not shared with the sodium-channel forms of familial sick
  sinus syndrome, is co-segregation of left ventricular noncompaction
  cardiomyopathy (and, in some pedigrees, dilation of the ascending aorta) with
  the bradycardia, indicating that the same channel lesion also perturbs
  myocardial development.
disease_term:
  preferred_term: sick sinus syndrome 2, autosomal dominant
  term:
    id: MONDO:0008102
    label: sick sinus syndrome 2, autosomal dominant
parents:
- Familial Sick Sinus Syndrome
- Channelopathy
synonyms:
- SSS2
- HCN4 sick sinus syndrome
- sick sinus syndrome caused by mutation in HCN4
- HCN4-related sinus node dysfunction
- familial sinus bradycardia, HCN4-related
classifications:
  harrisons_chapter:
  - classification_value: CARDIOVASCULAR
    evidence:
    - reference: PMID:17646576
      reference_title: "Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        We describe an inherited, autosomal-dominant form of sinus node
        dysfunction caused by a missense mutation in the HCN4 ion channel pore.
      explanation: >-
        SSS2 is a disorder of cardiac impulse generation and belongs with the
        cardiovascular disorders.
  - classification_value: GENETICS_ENVIRONMENT_DISEASE
    evidence:
    - reference: PMID:17646576
      reference_title: "Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Direct sequencing of the exons encoding HCN4 revealed a missense
        mutation, G480R, in the ion channel pore domain in all affected family
        members.
      explanation: >-
        SSS2 is a Mendelian single-gene disorder defined by a segregating HCN4
        variant, so it also belongs to the genetics Part.
  channelopathy_category:
    classification_value: cardiac channelopathy
    notes: >-
      SSS2 is a cardiac channelopathy of the pacemaker (funny) current rather
      than of a repolarizing current: the lesion depresses impulse generation in
      the sinoatrial node instead of destabilizing ventricular repolarization.
    evidence:
    - reference: PMID:26835093
      reference_title: "HCN4, Sinus Bradycardia and Atrial Fibrillation."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        All mutations described so far are loss-of-function and in agreement
        with the role of funny channels, the predominant type of arrhythmia
        found is bradycardia.
      explanation: >-
        A dedicated review of HCN4 channel mutations frames the disorder as a
        loss-of-function funny-channel channelopathy producing bradycardia.
inheritance:
- name: Autosomal dominant
  description: >-
    SSS2 segregates as an autosomal dominant trait. All reported disease
    variants are heterozygous, and the dominant mechanism is usually
    dominant-negative suppression of wild-type HCN4 subunits within the
    heterotetrameric channel rather than simple haploinsufficiency. Penetrance
    and expressivity vary widely, from asymptomatic sinus bradycardia detected
    only on screening to syncope requiring pacemaker implantation.
  inheritance_term:
    preferred_term: Autosomal dominant inheritance
    term:
      id: HP:0000006
      label: Autosomal dominant inheritance
  evidence:
  - reference: PMID:17646576
    reference_title: "Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Electrophysiological testing performed on 2 affected family members
      confirmed significant isolated sinus node dysfunction. Segregation
      analysis suggested autosomal-dominant inheritance.
    explanation: >-
      Formal segregation analysis in a 16-member HCN4-G480R family established
      autosomal dominant transmission of isolated sinus node dysfunction.
  - reference: PMID:12750403
    reference_title: "Pacemaker channel dysfunction in a patient with sinus node disease."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Coexpression experiments showed a dominant-negative effect of HCN4-573X
      subunits on wild-type subunits.
    explanation: >-
      Co-expression of mutant with wild-type subunits demonstrates the
      dominant-negative mechanism underlying dominant transmission.
mechanistic_hypotheses:
- hypothesis_group_id: sinoatrial_automaticity_failure_model
  hypothesis_label: Sinoatrial Pacemaker Automaticity Failure Model (HCN4 specialization)
  status: CANONICAL
  description: >-
    The disease-specific specialization of the module-level
    cardiac_ion_channel_repolarization group of the same name. In SSS2 the
    depressed current is specifically the hyperpolarization-activated funny
    current I_f carried by HCN4, so the bradyarrhythmia arises from a slowed
    diastolic depolarization slope in sinoatrial pacemaker cells rather than
    from depressed sodium-dependent conduction, and syncope follows from
    hypoperfusion during pauses rather than from ventricular tachyarrhythmia.
  evidence:
  - reference: PMID:16407510
    reference_title: "Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      These changes, which mimic those of mild vagal stimulation, slow the heart
      rate by decreasing the inward diastolic current.
    explanation: >-
      Names the funny-current-specific route to bradycardia that distinguishes
      this specialization from the sodium-channel arm of the module group.
  - reference: PMID:26835093
    reference_title: "HCN4, Sinus Bradycardia and Atrial Fibrillation."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      All mutations described so far are loss-of-function and in agreement with
      the role of funny channels, the predominant type of arrhythmia found is
      bradycardia.
    explanation: >-
      Confirms that the HCN4 arm of the model consistently yields bradyarrhythmia
      rather than tachyarrhythmia.
pathophysiology:
- name: HCN4 Loss-of-Function Variant
  conforms_to: "cardiac_ion_channel_repolarization#Cardiac Ion-Channel or Calcium-Handling Variant"
  role: trigger
  biological_scale: MOLECULAR
  description: >-
    A heterozygous loss-of-function variant in HCN4 alters the pore-forming
    subunit of the cardiac pacemaker channel. Reported disease alleles cluster
    in three structural regions with three corresponding biophysical
    consequences: pore-domain missense changes (G480R, G482R) that impair
    channel synthesis, trafficking, and gating; C-linker and
    cyclic-nucleotide-binding-domain changes (S672R, K530N) that shift
    activation gating; and C-terminal truncations (573X, 695X) that delete the
    cyclic-nucleotide-binding domain. All are heterozygous, and most act
    dominant-negatively on wild-type subunits within the heterotetramer.
  genes:
  - preferred_term: HCN4
    term:
      id: hgnc:16882
      label: HCN4
  molecular_functions:
  - preferred_term: intracellularly cAMP-activated cation channel activity
    term:
      id: GO:0005222
      label: intracellularly cAMP-activated cation channel activity
    modifier: DECREASED
  cell_types:
  - preferred_term: cardiac pacemaker cell of sinoatrial node
    term:
      id: CL:1000477
      label: cardiac pacemaker cell of sinoatrial node
  locations:
  - preferred_term: sinoatrial node
    term:
      id: UBERON:0002351
      label: sinoatrial node
  evidence:
  - reference: PMID:16407510
    reference_title: "Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We found that sinus bradycardia in members of a large family was
      associated with a mutation in the gene coding for the pacemaker HCN4 ion
      channel.
    explanation: >-
      The founding family study links a heterozygous HCN4 variant to inherited
      sinus bradycardia.
  - reference: PMID:17646576
    reference_title: "Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Synthesis and expression of the wild-type and mutant HCN4 channel on the
      plasma membrane tested in human embryonic kidney 293 cells using
      biotinylation and Western blot analysis demonstrated a reduction in
      synthesis and a trafficking defect in mutant compared with wild-type
      channels.
    explanation: >-
      Documents the synthesis/trafficking route to reduced channel availability
      for the pore-domain class of HCN4 alleles.
  - reference: PMID:26835093
    reference_title: "HCN4, Sinus Bradycardia and Atrial Fibrillation."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      All mutations described so far are loss-of-function and in agreement with
      the role of funny channels, the predominant type of arrhythmia found is
      bradycardia.
    explanation: >-
      Confirms that the HCN4 disease alleles reported to date are uniformly
      loss-of-function.
  downstream:
  - target: Reduced Funny Current and Slowed Diastolic Depolarization
    causal_link_type: DIRECT
    description: >-
      Reduced channel availability, a hyperpolarizing shift of the activation
      curve, or dominant-negative suppression of wild-type subunits lowers the
      inward diastolic current carried by I_f.
    hypothesis_groups:
    - sinoatrial_automaticity_failure_model
  - target: Loss of cAMP-Dependent Rate Modulation
    causal_link_type: DIRECT
    description: >-
      Truncations that remove the cyclic-nucleotide-binding domain, and
      C-linker changes that alter its coupling to the gate, uncouple the
      pacemaker current from cAMP.
  - target: Impaired Ventricular Trabecular Compaction
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      In several pedigrees the same HCN4 allele co-segregates with left
      ventricular noncompaction, implicating the channel in myocardial
      development; the intermediate steps are not established.
- name: Reduced Funny Current and Slowed Diastolic Depolarization
  role: central_effector
  biological_scale: CELLULAR
  description: >-
    The funny current I_f is the hyperpolarization-activated inward cation
    current that drives the early phase of spontaneous diastolic depolarization
    in sinoatrial node pacemaker cells. Mutant HCN4 channels activate at more
    negative voltages than wild-type channels, so at the diastolic potentials
    actually reached by a pacemaker cell less inward current flows. The
    diastolic depolarization slope falls, the interval to threshold lengthens,
    and the intrinsic firing rate of the node drops. The biophysical change has
    been described as mimicking mild vagal stimulation — a permanent,
    genetically imposed version of a physiological brake.
  cell_types:
  - preferred_term: cardiac pacemaker cell of sinoatrial node
    term:
      id: CL:1000477
      label: cardiac pacemaker cell of sinoatrial node
  biological_processes:
  - preferred_term: membrane depolarization during SA node cell action potential
    term:
      id: GO:0086046
      label: membrane depolarization during SA node cell action potential
    modifier: DECREASED
  - preferred_term: SA node cell action potential
    term:
      id: GO:0086015
      label: SA node cell action potential
    modifier: DECREASED
  locations:
  - preferred_term: sinoatrial node
    term:
      id: UBERON:0002351
      label: sinoatrial node
  evidence:
  - reference: PMID:12750403
    reference_title: "Pacemaker channel dysfunction in a patient with sinus node disease."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The cardiac pacemaker current I(f) is a major determinant of diastolic
      depolarization in sinus nodal cells and has a key role in heartbeat
      generation.
    explanation: >-
      Establishes the normal role of I_f in diastolic depolarization that is
      lost in SSS2.
  - reference: PMID:16407510
    reference_title: "Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      These changes, which mimic those of mild vagal stimulation, slow the heart
      rate by decreasing the inward diastolic current.
    explanation: >-
      States the biophysical mechanism directly: less inward diastolic current
      slows the heart rate.
  - reference: PMID:23178648
    reference_title: "Altered HCN4 channel C-linker interaction is associated with familial tachycardia-bradycardia syndrome and atrial fibrillation."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      In contrast, heteromeric channels composed of mutant and wild-type
      subunits displayed a significant hyperpolarizing shift in the half-maximal
      activation voltage.
    explanation: >-
      Shows that the hyperpolarizing gating shift emerges specifically in
      heteromeric mutant/wild-type channels, the situation in a heterozygous
      carrier.
  downstream:
  - target: Sinoatrial Node Automaticity Failure
    causal_link_type: DIRECT
    description: >-
      A slower diastolic depolarization slope lengthens the pacemaker cycle and
      depresses automaticity of the node as a whole.
    hypothesis_groups:
    - sinoatrial_automaticity_failure_model
- name: Loss of cAMP-Dependent Rate Modulation
  role: effector
  biological_scale: MOLECULAR
  description: >-
    Beta-adrenergic stimulation raises intracellular cAMP, which binds the
    cyclic-nucleotide-binding domain of HCN4 and shifts activation to more
    positive voltages, accelerating diastolic depolarization; vagal tone does
    the reverse. Truncating HCN4 alleles such as 573X delete this domain
    entirely, so the residual current is insensitive to cAMP. This is the
    proposed mechanistic basis of chronotropic incompetence in SSS2 — a failure
    of rate adaptation that is separable from the resting bradycardia. The
    corresponding mouse model shows that cAMP sensitivity of I_f sets basal and
    maximal heart rate while relative rate regulation during exercise is
    partially preserved by other mechanisms.
  cell_types:
  - preferred_term: cardiac pacemaker cell of sinoatrial node
    term:
      id: CL:1000477
      label: cardiac pacemaker cell of sinoatrial node
  biological_processes:
  - preferred_term: regulation of heart rate
    term:
      id: GO:0002027
      label: regulation of heart rate
    modifier: DECREASED
  - preferred_term: regulation of SA node cell action potential
    term:
      id: GO:0098907
      label: regulation of SA node cell action potential
    modifier: DECREASED
  evidence:
  - reference: PMID:12750403
    reference_title: "Pacemaker channel dysfunction in a patient with sinus node disease."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Patch-clamp experiments showed that HCN4-573X channels mediated I(f)-like
      currents that were insensitive to increased cellular cAMP levels.
    explanation: >-
      Direct demonstration that a truncating HCN4 allele abolishes cAMP
      responsiveness of the pacemaker current.
  - reference: PMID:12750403
    reference_title: "Pacemaker channel dysfunction in a patient with sinus node disease."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Taken together, the clinical, genetic, and in vitro data provide a likely
      explanation for the patient's sinus bradycardia and the chronotropic
      incompetence.
    explanation: >-
      Links the cAMP-insensitive channel phenotype to the patient's chronotropic
      incompetence.
  - reference: PMID:19570998
    reference_title: "Control of heart rate by cAMP sensitivity of HCN channels."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Our data demonstrate that cAMP-mediated regulation of I(f) determines
      basal and maximal heart rates but does not play an indispensable role in
      heart rate adaptation during physical activity.
    explanation: >-
      A mouse model of the human 573X allele shows cAMP sensitivity of I_f sets
      basal and maximal rate; graded PARTIAL because it also shows relative
      exercise rate adaptation is preserved, qualifying the chronotropic claim.
  downstream:
  - target: Chronotropic Incompetence
    causal_link_type: DIRECT
    description: >-
      Without cAMP-dependent acceleration of the pacemaker current, heart rate
      fails to rise appropriately with sympathetic drive.
  - target: Sinoatrial Node Automaticity Failure
    causal_link_type: DIRECT
    description: >-
      Loss of the cAMP-dependent positive shift lowers the operating range of
      pacemaker firing, compounding the resting depression of automaticity.
- name: Sinoatrial Node Automaticity Failure
  conforms_to: "cardiac_ion_channel_repolarization#Sinoatrial Node Pacemaker Dysfunction"
  role: effector
  biological_scale: TISSUE
  description: >-
    Depressed pacemaker-cell firing translates into failure of the sinoatrial
    node to generate and deliver impulses at an appropriate rate: sinus
    bradycardia at rest, intermittent sinus pauses or arrest, and an inadequate
    rate response to demand. Because the node also anchors atrial activation,
    chronic bradycardia and the associated atrial electrical and structural
    remodeling raise susceptibility to atrial fibrillation, giving the
    tachycardia-bradycardia pattern that is unusually common in HCN4 carriers.
  cell_types:
  - preferred_term: cardiac pacemaker cell of sinoatrial node
    term:
      id: CL:1000477
      label: cardiac pacemaker cell of sinoatrial node
  biological_processes:
  - preferred_term: cardiac conduction
    term:
      id: GO:0061337
      label: cardiac conduction
    modifier: DECREASED
  - preferred_term: regulation of heart rate by cardiac conduction
    term:
      id: GO:0086091
      label: regulation of heart rate by cardiac conduction
    modifier: DECREASED
  locations:
  - preferred_term: sinoatrial node
    term:
      id: UBERON:0002351
      label: sinoatrial node
  evidence:
  - reference: PMID:17646576
    reference_title: "Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Electrophysiological testing performed on 2 affected family members
      confirmed significant isolated sinus node dysfunction.
    explanation: >-
      Invasive electrophysiology in HCN4-G480R carriers confirms isolated
      sinoatrial node dysfunction as the tissue-level lesion.
  - reference: PMID:16407510
    reference_title: "Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Thus, diminished function of pacemaker channels is linked to familial
      bradycardia.
    explanation: >-
      States the causal chain from diminished pacemaker-channel function to the
      familial bradycardia phenotype.
  downstream:
  - target: Sinus Bradycardia
    causal_link_type: DIRECT
    description: Depressed nodal firing rate presents as resting sinus bradycardia.
  - target: Sinus Pauses and Sinus Arrest
    causal_link_type: DIRECT
    description: >-
      Intermittent failure of impulse formation produces sinus pauses and
      asystolic gaps.
  - target: Atrial Fibrillation
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - bradycardia-associated atrial electrical and structural remodeling
    description: >-
      Chronic bradycardia and atrial remodeling raise susceptibility to atrial
      fibrillation, producing tachycardia-bradycardia syndrome.
  - target: Syncope and Sudden Cardiac Death
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - prolonged sinus pauses and asystole
    - cerebral hypoperfusion
    description: >-
      Severe bradycardia or a prolonged pause reduces cerebral perfusion,
      producing presyncope and syncope.
    hypothesis_groups:
    - sinoatrial_automaticity_failure_model
- name: Impaired Ventricular Trabecular Compaction
  role: effector
  biological_scale: TISSUE
  description: >-
    HCN4 is expressed during cardiac development, and in several independent
    pedigrees the same segregating HCN4 allele produces both bradycardia and
    left ventricular noncompaction — a myocardium with a persistently
    trabeculated, poorly compacted layer and deep intertrabecular recesses.
    This developmental arm is what distinguishes the HCN4 form of familial sick
    sinus syndrome from the sodium-channel forms, in which no structural
    abnormality is found. It is curated here as a parallel branch of the same
    genetic lesion rather than as maladaptive remodeling secondary to the
    arrhythmia: the noncompaction is present from childhood and does not follow
    a preceding phase of cardiomyocyte injury and neurohormonal activation.
    Some pedigrees additionally show dilation of the ascending aorta.
  cell_types:
  - preferred_term: cardiac muscle cell
    term:
      id: CL:0000746
      label: cardiac muscle cell
  biological_processes:
  - preferred_term: ventricular trabecula myocardium morphogenesis
    term:
      id: GO:0003222
      label: ventricular trabecula myocardium morphogenesis
    modifier: ABNORMAL
  locations:
  - preferred_term: heart left ventricle
    term:
      id: UBERON:0002084
      label: heart left ventricle
  evidence:
  - reference: PMID:25145517
    reference_title: "HCN4 mutations in multiple families with bradycardia and left ventricular noncompaction cardiomyopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      One of these, p.Gly482Arg in HCN4, segregated with the combined
      bradycardia and LVNC phenotype in the entire family.
    explanation: >-
      Establishes co-segregation of a single HCN4 allele with both the
      electrical and the structural phenotype.
  - reference: PMID:25145517
    reference_title: "HCN4 mutations in multiple families with bradycardia and left ventricular noncompaction cardiomyopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Although mutations in HCN4 have been previously linked to bradycardia, our
      study provides the first evidence to our knowledge that mutations in this
      ion channel gene also may be associated with structural abnormalities of
      the myocardium.
    explanation: >-
      States explicitly that HCN4 variants can produce a structural myocardial
      abnormality, not only an electrical one.
  - reference: PMID:25145518
    reference_title: "The symptom complex of familial sinus node dysfunction and myocardial noncompaction is associated with mutations in the HCN4 channel."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The symptom complex of SND and NCCM is associated with heritable HCN4
      defects.
    explanation: >-
      An independent German cohort reaches the same conclusion for the combined
      sinus-node/noncompaction phenotype.
  downstream:
  - target: Left Ventricular Noncompaction
    causal_link_type: DIRECT
    description: >-
      Failure of trabecular compaction gives the two-layered noncompacted
      myocardium seen on echocardiography and cardiac MRI.
  - target: Dilatation of the Ascending Aorta
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Ascending aortic dilation accompanies the noncompaction phenotype in some
      HCN4 families; the mechanism linking the channel to the aortic wall is
      unknown.
- name: Syncope and Sudden Cardiac Death
  conforms_to: "cardiac_ion_channel_repolarization#Syncope and Sudden Cardiac Death"
  role: outcome
  biological_scale: ORGANISM
  description: >-
    Severe bradycardia or a prolonged sinus pause transiently abolishes
    effective cardiac output, producing presyncope and syncope from cerebral
    hypoperfusion; an unterminated pause carries a risk of asystolic sudden
    death. This is the shared clinical endpoint with the other inherited
    arrhythmia syndromes, reached in SSS2 through bradyarrhythmia rather than
    ventricular tachyarrhythmia. Prognosis is variable and allele-dependent:
    the G480R pore-domain family remained asymptomatic with normal exercise
    capacity throughout long-term follow-up and required no pacemaker.
  evidence:
  - reference: PMID:34383451
    reference_title: "Sinus Node Dysfunction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      About 50% of patients present with cerebral hypoperfusion (e.g., syncope,
      presyncope, lightheadedness, cerebrovascular accident).
    explanation: >-
      Supports cerebral hypoperfusion (syncope/presyncope) as the clinical
      endpoint of symptomatic sinus node dysfunction.
  - reference: PMID:17646576
    reference_title: "Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Despite its critical location, this mutation carries a favorable prognosis
      without the need for pacemaker implantation during long-term follow-up.
    explanation: >-
      Qualifies the outcome node: at least one HCN4 pore-domain allele carries a
      benign long-term course, so the outcome is allele- and family-dependent.
phenotypes:
- name: Sinus Bradycardia
  category: Cardiovascular
  description: >-
    Persistently slow sinus rate arising from the reduced diastolic
    depolarization slope of HCN4-mutant pacemaker cells. It is the cardinal and
    most penetrant manifestation of SSS2 and is often the finding that brings a
    family to genetic attention, sometimes in an entirely asymptomatic carrier.
  phenotype_term:
    preferred_term: Sinus bradycardia
    term:
      id: HP:0001688
      label: Sinus bradycardia
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:16407510
    reference_title: "Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We found that sinus bradycardia in members of a large family was
      associated with a mutation in the gene coding for the pacemaker HCN4 ion
      channel.
    explanation: >-
      Sinus bradycardia is the defining familial phenotype in the founding HCN4
      pedigree.
  - reference: PMID:35328031
    reference_title: "Clinical Presentation of Left Ventricular Noncompaction Cardiomyopathy and Bradycardia in Three Families Carrying HCN4 Pathogenic Variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Sinus bradycardia and dilation of the ascending aorta occurred in five
      studied patients.
    explanation: >-
      Supports the VERY_FREQUENT band: sinus bradycardia was present in five of
      the six prospectively enrolled patients in this HCN4/LVNC series.
- name: Sick Sinus Syndrome
  category: Cardiovascular
  description: >-
    The composite clinical syndrome of sinoatrial node dysfunction —
    inappropriate bradycardia, pauses, chronotropic incompetence and
    bradycardia-tachycardia alternation — which in SSS2 is the direct
    consequence of the pacemaker-current defect rather than of age-related
    nodal fibrosis.
  phenotype_term:
    preferred_term: Sick sinus syndrome
    term:
      id: HP:0011704
      label: Sick sinus syndrome
  evidence:
  - reference: PMID:28104484
    reference_title: "Sick sinus syndrome with HCN4 mutations shows early onset and frequent association with atrial fibrillation and left ventricular noncompaction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      SSS with HCN4 mutations may form a distinct SSS subgroup characterized by
      early clinical manifestation after adolescence and frequent association
      with AF and LVNC.
    explanation: >-
      Defines HCN4-related disease as a distinct clinical subgroup of sick sinus
      syndrome.
- name: Sinus Pauses and Sinus Arrest
  category: Cardiovascular
  description: >-
    Intermittent failure of sinoatrial impulse formation producing asystolic
    gaps on the electrocardiogram or Holter recording. Pauses are the proximate
    cause of presyncope and syncope in symptomatic carriers and the usual
    trigger for pacemaker implantation.
  phenotype_term:
    preferred_term: Abnormal electrophysiology of sinoatrial node origin
    term:
      id: HP:0011702
      label: Abnormal electrophysiology of sinoatrial node origin
  evidence:
  - reference: PMID:34383451
    reference_title: "Sinus Node Dysfunction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Electrocardiography findings include sinus bradycardia, sinus pauses or
      arrest, sinoatrial exit block, chronotropic incompetence, or alternating
      bradycardia and tachycardia (i.e., bradycardia-tachycardia syndrome).
    explanation: >-
      Sinus pauses and arrest are core electrocardiographic manifestations of
      sinus node dysfunction, the syndrome SSS2 produces.
- name: Chronotropic Incompetence
  category: Cardiovascular
  description: >-
    Failure of the heart rate to rise appropriately with metabolic demand. In
    SSS2 this is mechanistically distinct from the resting bradycardia: it
    follows from loss of cAMP-dependent modulation of the pacemaker current, so
    it is most pronounced for alleles that delete or uncouple the
    cyclic-nucleotide-binding domain. It is not universal — the G480R pore
    family had normal exercise capacity.
  phenotype_term:
    preferred_term: Chronotropic incompetence
    term:
      id: HP:0033992
      label: Chronotropic incompetence
  evidence:
  - reference: PMID:12750403
    reference_title: "Pacemaker channel dysfunction in a patient with sinus node disease."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Taken together, the clinical, genetic, and in vitro data provide a likely
      explanation for the patient's sinus bradycardia and the chronotropic
      incompetence.
    explanation: >-
      Documents chronotropic incompetence in the index HCN4-573X patient and
      attributes it to the cAMP-insensitive pacemaker channel.
  - reference: PMID:17646576
    reference_title: "Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia."
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      All affected family members were asymptomatic with normal exercise
      capacity during long-term follow-up.
    explanation: >-
      Counter-evidence that chronotropic incompetence is not obligate in SSS2:
      the HCN4-G480R family retained normal exercise capacity.
- name: Atrial Fibrillation
  category: Cardiovascular
  description: >-
    Disorganized atrial electrical activity with an irregularly irregular
    ventricular response. Atrial fibrillation is strikingly common in HCN4
    carriers — reported in 43.8% in a meta-analysis of HCN4 probands — and
    frequently alternates with the bradycardia as tachycardia-bradycardia
    syndrome.
  phenotype_term:
    preferred_term: Atrial fibrillation
    term:
      id: HP:0005110
      label: Atrial fibrillation
  frequency: FREQUENT
  evidence:
  - reference: PMID:28104484
    reference_title: "Sick sinus syndrome with HCN4 mutations shows early onset and frequent association with atrial fibrillation and left ventricular noncompaction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Moreover, HCN4 mutation carriers were more frequently associated with AF
      (43.8%) and LVNC (50%) and with older age at pacemaker implantation
    explanation: >-
      Quantifies atrial fibrillation at 43.8% of HCN4 mutation carriers,
      supporting the FREQUENT band (30-79%).
  - reference: PMID:23178648
    reference_title: "Altered HCN4 channel C-linker interaction is associated with familial tachycardia-bradycardia syndrome and atrial fibrillation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The index patient developed tachycardia-bradycardia syndrome and
      persistent atrial fibrillation (AF) in an age-dependent fashion. Pedigree
      analysis identified eight affected family members with a similar course of
      disease.
    explanation: >-
      An HCN4 pedigree in which tachycardia-bradycardia syndrome with persistent
      atrial fibrillation is the segregating phenotype.
- name: Left Ventricular Noncompaction
  category: Cardiovascular
  description: >-
    A two-layered left ventricular myocardium with prominent trabeculations and
    deep intertrabecular recesses over a thin compacted layer. It co-segregates
    with the bradycardia in multiple independent HCN4 families and was reported
    in 50% of HCN4 mutation carriers in a meta-analysis, making it the
    distinguishing extra-electrical feature of SSS2.
  phenotype_term:
    preferred_term: Left ventricular noncompaction
    term:
      id: HP:0030682
      label: Left ventricular noncompaction
  frequency: FREQUENT
  evidence:
  - reference: PMID:28104484
    reference_title: "Sick sinus syndrome with HCN4 mutations shows early onset and frequent association with atrial fibrillation and left ventricular noncompaction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Moreover, HCN4 mutation carriers were more frequently associated with AF
      (43.8%) and LVNC (50%) and with older age at pacemaker implantation
    explanation: >-
      Quantifies left ventricular noncompaction at 50% of HCN4 mutation
      carriers, supporting the FREQUENT band (30-79%).
  - reference: PMID:25145517
    reference_title: "HCN4 mutations in multiple families with bradycardia and left ventricular noncompaction cardiomyopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Subsequent screening of HCN4 in 3 additional families with the same
      clinical combination of bradycardia and LVNC identified HCN4 mutations in
      each.
    explanation: >-
      Replication across three additional families establishes noncompaction as
      part of the HCN4 phenotype rather than a chance co-occurrence.
- name: Dilatation of the Ascending Aorta
  category: Cardiovascular
  description: >-
    Enlargement of the ascending aorta beyond a body-surface-area-indexed
    z-score of 2, reported alongside noncompaction and bradycardia in HCN4
    families. The mechanism connecting the pacemaker channel to the aortic wall
    is unknown, and this feature is not part of the classical SSS2 description.
  phenotype_term:
    preferred_term: Dilatation of the ascending aorta
    term:
      id: HP:0004970
      label: Ascending tubular aorta aneurysm
  evidence:
  - reference: PMID:35328031
    reference_title: "Clinical Presentation of Left Ventricular Noncompaction Cardiomyopathy and Bradycardia in Three Families Carrying HCN4 Pathogenic Variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The HCN4 molecular variants influence the presence of a complex LVNC
      phenotype, sinus bradycardia and dilation of the ascending aorta.
    explanation: >-
      Reports ascending aortic dilation in HCN4 families. The HPO binding is
      exact rather than approximate — "Dilatation of ascending aorta" is an
      EXACT synonym of HP:0004970, and the source measured the ascending aorta
      in the parasternal long-axis view indexed to body surface area, the same
      segment the term names. Graded PARTIAL because the series is small (six
      patients, four families) and the mechanism linking the pacemaker channel
      to the aortic wall is unknown.
- name: Syncope
  category: Neurologic
  description: >-
    Transient loss of consciousness from abrupt cerebral hypoperfusion during a
    prolonged sinus pause or severe bradycardia. Syncope is the usual
    symptomatic presentation that leads to device therapy in SSS2, but many
    carriers ascertained through family screening never have an episode.
  phenotype_term:
    preferred_term: Syncope
    term:
      id: HP:0001279
      label: Syncope
  evidence:
  - reference: PMID:34383451
    reference_title: "Sinus Node Dysfunction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      About 50% of patients present with cerebral hypoperfusion (e.g., syncope,
      presyncope, lightheadedness, cerebrovascular accident).
    explanation: >-
      Syncope is a direct manifestation of the cerebral hypoperfusion caused by
      sinus node dysfunction.
- name: Atrioventricular Block
  category: Cardiovascular
  description: >-
    Impaired conduction from atria to ventricles. HCN4 is expressed throughout
    the cardiac conduction system, not only in the sinoatrial node, and AV block
    is part of the reported funny-channel arrhythmia spectrum, though it is much
    less consistent than the sinus-node phenotype.
  phenotype_term:
    preferred_term: Atrioventricular block
    term:
      id: HP:0001678
      label: Atrioventricular block
  evidence:
  - reference: PMID:26835093
    reference_title: "HCN4, Sinus Bradycardia and Atrial Fibrillation."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Funny channel-linked arrhythmias, however, also include atrioventricular
      (AV) block and atrial fibrillation, in agreement with an emerging new
      concept according to which defective funny channels have a still
      unexplored role in impairing AV conduction and triggering atrial
      fibrillation.
    explanation: >-
      A review places AV block in the HCN4 arrhythmia spectrum; graded PARTIAL
      because the review itself describes the AV-conduction role as an emerging
      and still unexplored concept.
genetic:
- name: HCN4 loss-of-function variants
  association: Causative
  relationship_type: CAUSATIVE
  gene_term:
    preferred_term: HCN4
    term:
      id: hgnc:16882
      label: HCN4
  features: >-
    Heterozygous loss-of-function variants in HCN4 are the sole established
    cause of SSS2. Reported alleles include pore-domain missense changes (G480R,
    G482R), C-linker and cyclic-nucleotide-binding-domain changes (K530N,
    S672R), and C-terminal truncations (573X, 695X). Loss of function is
    achieved by a hyperpolarizing shift in the voltage dependence of activation,
    by reduced channel synthesis and defective trafficking, or by loss of cAMP
    responsiveness; most alleles additionally suppress wild-type subunits within
    the heterotetramer.
  case_fractions:
  - population: 38 unrelated familial sick sinus syndrome families, genetic screening cohort
    case_fraction_percent: 5.3
    cohort_size: 38
    notes: >-
      Two of 38 unrelated familial SSS families carried an HCN4
      loss-of-function variant (three carried SCN5A), so HCN4 accounts for a
      minority of familial sick sinus syndrome overall even though it defines
      SSS2.
    evidence:
    - reference: PMID:28104484
      reference_title: "Sick sinus syndrome with HCN4 mutations shows early onset and frequent association with atrial fibrillation and left ventricular noncompaction."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        We genetically screened 38 unrelated SSS families and functionally
        analyzed the mutant SCN5A and HCN4 channels by patch clamping.
      explanation: >-
        Gives the denominator (38 unrelated familial SSS families) for the HCN4
        case fraction.
    - reference: PMID:28104484
      reference_title: "Sick sinus syndrome with HCN4 mutations shows early onset and frequent association with atrial fibrillation and left ventricular noncompaction."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        We identified two HCN4 and three SCN5A loss-of-function mutations in our
        familial SSS cohort.
      explanation: >-
        Gives the numerator (two HCN4 families) for the HCN4 case fraction.
  variants:
  - name: HCN4 p.Ser672Arg
    description: >-
      Missense change near the cyclic-nucleotide-binding site, identified in a
      large familial sinus bradycardia pedigree. Mutant channels retain a normal
      response to cAMP but activate at more negative voltages than wild-type,
      reducing the inward diastolic current.
    gene:
      preferred_term: HCN4
      term:
        id: hgnc:16882
        label: HCN4
    evidence:
    - reference: PMID:16407510
      reference_title: "Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        The mutation associated with bradycardia is located near the
        cAMP-binding site; functional analysis found that mutant channels
        respond normally to cAMP but are activated at more negative voltages
        than are wild-type channels.
      explanation: >-
        Characterizes the gating-shift mechanism of this allele.
  - name: HCN4 573X (c.1631delC)
    description: >-
      Heterozygous single-base deletion in exon 5 producing a C-terminally
      truncated subunit that lacks the cyclic-nucleotide-binding domain.
      Trafficking is normal, but the resulting current is cAMP-insensitive and
      the subunit exerts a dominant-negative effect on wild-type channels.
    gene:
      preferred_term: HCN4
      term:
        id: hgnc:16882
        label: HCN4
    evidence:
    - reference: PMID:12750403
      reference_title: "Pacemaker channel dysfunction in a patient with sinus node disease."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        In a candidate gene approach, a heterozygous 1-bp deletion (1631delC) in
        exon 5 of the human HCN4 gene was detected in a patient with idiopathic
        SND.
      explanation: >-
        Identifies the truncating allele in the index patient with idiopathic
        sinus node dysfunction.
    - reference: PMID:12750403
      reference_title: "Pacemaker channel dysfunction in a patient with sinus node disease."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        The mutant HCN4 protein (HCN4-573X) had a truncated C-terminus and
        lacked the cyclic nucleotide-binding domain.
      explanation: >-
        Establishes the structural basis for the loss of cAMP responsiveness.
  - name: HCN4 p.Gly480Arg
    description: >-
      Pore-domain missense change segregating with autosomal dominant isolated
      sinus node dysfunction in a 16-member family. Reduces channel synthesis
      and membrane trafficking and shifts activation to more negative voltages,
      yet carries a benign long-term course.
    gene:
      preferred_term: HCN4
      term:
        id: hgnc:16882
        label: HCN4
    evidence:
    - reference: PMID:17646576
      reference_title: "Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Direct sequencing of the exons encoding HCN4 revealed a missense
        mutation, G480R, in the ion channel pore domain in all affected family
        members.
      explanation: >-
        Establishes complete co-segregation of the pore-domain allele with the
        affected status.
  - name: HCN4 p.Gly482Arg
    description: >-
      Pore-domain missense change segregating with the combined sinus node
      dysfunction and biventricular noncompaction phenotype. Mutant subunits are
      nonfunctional and dominant-negative on wild-type current.
    gene:
      preferred_term: HCN4
      term:
        id: hgnc:16882
        label: HCN4
    evidence:
    - reference: PMID:25145518
      reference_title: "The symptom complex of familial sinus node dysfunction and myocardial noncompaction is associated with mutations in the HCN4 channel."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        HCN4-G482R is located in the highly conserved channel pore domain.
        Mutant subunits were nonfunctional and exerted dominant-negative effects
        on wild-type current.
      explanation: >-
        Characterizes the dominant-negative loss-of-function mechanism of this
        allele.
  - name: HCN4 p.Lys530Asn
    description: >-
      C-linker missense change identified by screening 422 patients with
      tachyarrhythmias. Homomeric mutant channels behave almost like wild-type;
      the loss of function appears only in heteromeric mutant/wild-type
      channels, which show a hyperpolarizing shift of half-maximal activation —
      the biophysical situation of a heterozygous carrier.
    gene:
      preferred_term: HCN4
      term:
        id: hgnc:16882
        label: HCN4
    evidence:
    - reference: PMID:23178648
      reference_title: "Altered HCN4 channel C-linker interaction is associated with familial tachycardia-bradycardia syndrome and atrial fibrillation."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        In a candidate gene approach, we screened 422 patients with atrial
        and/or ventricular tachyarrhythmias and detected a novel HCN4 gene
        mutation that replaced the positively charged lysine 530 with an
        asparagine (HCN4-K530N) in a highly conserved region of the C-linker.
      explanation: >-
        Identifies the C-linker allele and the screening context in which it was
        found.
  evidence:
  - reference: PMID:26835093
    reference_title: "HCN4, Sinus Bradycardia and Atrial Fibrillation."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      All mutations described so far are loss-of-function and in agreement with
      the role of funny channels, the predominant type of arrhythmia found is
      bradycardia.
    explanation: >-
      Confirms the uniform loss-of-function direction of HCN4 disease alleles.
  - reference: PMID:16407510
    reference_title: "Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Thus, diminished function of pacemaker channels is linked to familial
      bradycardia.
    explanation: >-
      States the gene-disease relationship established by the founding pedigree.
animal_models:
- name: hHCN4-573X inducible cardiac transgenic mouse
  species: Mouse
  genotype: heart-specific, inducible expression of the human HCN4-573X allele
  description: >-
    Mice engineered for heart-specific, inducible expression of the human
    truncating HCN4-573X allele found in the index SSS2 patient. The model
    isolates the cAMP-insensitivity arm of the human mechanism.
  publication: PMID:19570998
  modeled_mechanisms:
  - target: Loss of cAMP-Dependent Rate Modulation
    relationship: RECAPITULATES
    fidelity: HIGH
    description: >-
      Expression of the human disease allele eliminates cAMP sensitivity of I_f
      in sinoatrial node cells and lowers resting and maximal heart rate, the
      mechanism proposed for the human carrier.
    limitations: >-
      The transgene is expressed heart-wide and inducibly rather than as a
      germline heterozygous allele, and murine sinoatrial physiology operates at
      a resting rate roughly an order of magnitude faster than human. The model
      also shows that relative rate adaptation during exercise is preserved, so
      it does not reproduce chronotropic incompetence as completely as the human
      case report implies.
    readouts:
    - name: cAMP sensitivity of I_f in sinoatrial node pacemaker cells
      target: Loss of cAMP-Dependent Rate Modulation
      direction: ABOLISHED
      interpretation: >-
        Direct molecular readout of the proposed human mechanism.
      evidence:
      - reference: PMID:19570998
        reference_title: "Control of heart rate by cAMP sensitivity of HCN channels."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: >-
          We found that hHCN4-573X expression causes elimination of the cAMP
          sensitivity of I(f) and decreases the maximum firing rates of SAN
          pacemaker cells.
        explanation: >-
          Reports elimination of cAMP sensitivity and reduced maximal pacemaker
          firing rate.
    - name: Heart rate in conscious mice at rest and during exercise
      target: Loss of cAMP-Dependent Rate Modulation
      direction: DECREASED
      interpretation: >-
        Whole-animal correlate of the human resting bradycardia and blunted
        maximal rate.
      evidence:
      - reference: PMID:19570998
        reference_title: "Control of heart rate by cAMP sensitivity of HCN channels."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: >-
          In conscious mice, hHCN4-573X expression leads to a marked reduction
          in heart rate at rest and during exercise.
        explanation: >-
          Direct in vivo measurement of the bradycardic phenotype.
    evidence:
    - reference: PMID:19570998
      reference_title: "Control of heart rate by cAMP sensitivity of HCN channels."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Our data also reveal the pathophysiologic mechanism of hHCN4-573X-linked
        SAN dysfunction in humans.
      explanation: >-
        The authors state explicitly that the model is informative for the human
        HCN4-573X sinoatrial node dysfunction mechanism.
- name: Inducible cardiac-specific HCN4 knockout mouse (ciHCN4-KO)
  species: Mouse
  genotype: inducible, cardiac-specific Hcn4 ablation in the adult
  description: >-
    Adult-onset, cardiac-specific ablation of Hcn4, which removes rather than
    alters the pacemaker channel. Establishes that HCN4 is required for normal
    impulse generation in the adult heart.
  publication: PMID:21220308
  modeled_mechanisms:
  - target: Sinoatrial Node Automaticity Failure
    relationship: PARTIALLY_RECAPITULATES
    fidelity: MODERATE
    description: >-
      Ablation reduces I_f and the spontaneous rate of isolated sinoatrial node
      myocytes and produces severe bradycardia in vivo, confirming that loss of
      HCN4 function is sufficient to depress nodal automaticity.
    limitations: >-
      Complete ablation of both alleles in the adult heart is a far more severe
      lesion than the heterozygous, partially functional channels of human SSS2:
      the mice progress to atrioventricular block, cardiac arrest and death
      within days, an outcome not seen in HCN4 carriers, so the model overstates
      severity and adds an AV-conduction phenotype not characteristic of the
      human disease.
    readouts:
    - name: HCN4 protein expression in sinoatrial node tissue and cells
      target: Sinoatrial Node Automaticity Failure
      direction: DECREASED
      interpretation: >-
        Confirms the molecular lesion underlying the depressed nodal
        automaticity measured in the same animals.
      evidence:
      - reference: PMID:21220308
        reference_title: "Deep bradycardia and heart block caused by inducible cardiac-specific knockout of the pacemaker channel gene Hcn4."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: >-
          In agreement with functional results, immunofluorescence and Western
          blot analysis showed reduced expression of HCN4 protein in SAN tissue
          and cells.
        explanation: >-
          Confirms loss of HCN4 protein in sinoatrial node tissue accompanying
          the functional deficit.
    evidence:
    - reference: PMID:21220308
      reference_title: "Deep bradycardia and heart block caused by inducible cardiac-specific knockout of the pacemaker channel gene Hcn4."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Our data show that cardiac HCN4 channels are essential for normal heart
        impulse generation and conduction in adult mice and support the notion
        that dysfunctional HCN4 channels can be a direct cause of rhythm
        disorders.
      explanation: >-
        States that the model supports dysfunctional HCN4 channels as a direct
        cause of rhythm disorders, the claim this entry makes for SSS2.
computational_models:
- name: Fabbri-Severi human sinoatrial node cell model with HCN4 mutation-induced I_f changes
  model_type: PHYSIOLOGICAL
  description: >-
    A published in-silico risk-stratification study of SSS2. In-vitro biophysical
    data for HCN4 loss-of-function alleles were used to compute the charge
    carried by I_f during diastolic depolarization of a prerecorded human
    sinoatrial node action potential, and that quantity was used to drive the
    Fabbri-Severi model of a human sinoatrial node pacemaker cell. It is the
    computational counterpart of the funny-current node in this entry: it makes
    the qualitative claim (less diastolic I_f, slower firing) quantitative and
    allele-specific.
  publication: PMID:37760888
  modeled_mechanisms:
  - target: Reduced Funny Current and Slowed Diastolic Depolarization
    relationship: MEASURES
    fidelity: MODERATE
    description: >-
      The simulated beating rate of the human sinoatrial node cell model tracks
      the computed diastolic I_f charge very closely, and the same quantity
      correlates strongly with the resting and minimum heart rates observed in
      carriers of the corresponding HCN4 mutations.
    limitations: >-
      The correlation with clinical heart rate is strong but not deterministic,
      the analysis is restricted to the subset of HCN4 alleles with both
      quantitative clinical and in-vitro data, and the authors state that a
      translational perspective remains to be established.
    evidence:
    - reference: PMID:37760888
      reference_title: "The Action Potential Clamp Technique as a Tool for Risk Stratification of Sinus Bradycardia Due to Loss-of-Function Mutations in HCN4: An In Silico Exploration Based on In Vitro and In Vivo Data."
      supports: SUPPORT
      evidence_source: COMPUTATIONAL
      snippet: >-
        The clinically observed minimum or resting heart rates showed a strong
        correlation with Qf
      explanation: >-
        Links the simulated diastolic funny-current charge to the heart rate
        actually measured in HCN4 mutation carriers.
  findings:
  - statement: >-
      The diastolic funny-current charge computed by action-potential clamp
      predicts both the simulated pacemaker rate of a human sinoatrial node cell
      model and the resting or minimum heart rate of HCN4 mutation carriers,
      making it a candidate risk-stratification measure for HCN4
      loss-of-function sinus bradycardia.
    evidence:
    - reference: PMID:37760888
      reference_title: "The Action Potential Clamp Technique as a Tool for Risk Stratification of Sinus Bradycardia Due to Loss-of-Function Mutations in HCN4: An In Silico Exploration Based on In Vitro and In Vivo Data."
      supports: SUPPORT
      evidence_source: COMPUTATIONAL
      snippet: >-
        The beating rate of the model cell showed a very strong correlation with
        Qf from the simulated action potential clamp experiments
      explanation: >-
        Reports the correlation between simulated pacemaker rate and diastolic
        funny-current charge that this finding states.
  evidence:
  - reference: PMID:37760888
    reference_title: "The Action Potential Clamp Technique as a Tool for Risk Stratification of Sinus Bradycardia Due to Loss-of-Function Mutations in HCN4: An In Silico Exploration Based on In Vitro and In Vivo Data."
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    snippet: >-
      HCN4 is the gene responsible for the hyperpolarization-activated 'funny'
      current If, which is an important modulator of the spontaneous diastolic
      depolarization underlying the sinus node pacemaker activity.
    explanation: >-
      States the mechanistic premise the simulation encodes, matching this
      entry's funny-current pathophysiology node.
diagnosis:
- name: Electrocardiography and ambulatory rhythm monitoring
  description: >-
    Resting ECG and 24-hour Holter monitoring document the sinus bradycardia,
    sinus pauses, and bradycardia-tachycardia alternation, and correlate them
    with symptoms. Exercise testing assesses chronotropic response.
  diagnosis_term:
    preferred_term: electrocardiography
    term:
      id: NCIT:C38053
      label: Electrocardiography
  evidence:
  - reference: PMID:34383451
    reference_title: "Sinus Node Dysfunction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Heart rate monitoring using electrocardiography or ambulatory cardiac
      event monitoring is performed based on the frequency of symptoms.
    explanation: >-
      Establishes ECG and ambulatory monitoring as the diagnostic modality for
      sinus node dysfunction.
- name: Cardiac imaging for noncompaction and aortic dimensions
  description: >-
    Because the HCN4 form uniquely carries a structural arm, echocardiography
    and cardiac magnetic resonance are needed to look for left ventricular
    noncompaction, late gadolinium enhancement, and dilation of the ascending
    aorta in a carrier who presents only with bradycardia.
  diagnosis_term:
    preferred_term: echocardiography
    term:
      id: NCIT:C16525
      label: Echocardiography Test
  evidence:
  - reference: PMID:35328031
    reference_title: "Clinical Presentation of Left Ventricular Noncompaction Cardiomyopathy and Bradycardia in Three Families Carrying HCN4 Pathogenic Variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      All six patients were diagnosed with LVNC by echocardiography, and five
      participants additionally by CMR.
    explanation: >-
      Documents echocardiography and cardiac MRI as the modalities that detect
      the structural arm in HCN4 families.
- name: Genetic testing of HCN4
  description: >-
    Targeted or panel sequencing of HCN4 confirms the diagnosis in a proband
    with familial or early-onset sinus node dysfunction, particularly when
    bradycardia is accompanied by noncompaction, and enables cascade screening
    of relatives, many of whom are asymptomatic.
  diagnosis_term:
    preferred_term: genetic testing
    term:
      id: NCIT:C15709
      label: Genetic Testing
  evidence:
  - reference: PMID:25145518
    reference_title: "The symptom complex of familial sinus node dysfunction and myocardial noncompaction is associated with mutations in the HCN4 channel."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Targeted next-generation and direct sequencing were used for candidate
      gene analysis and mutation scanning.
    explanation: >-
      Describes the sequencing approach used to establish the HCN4 diagnosis in
      families with the combined phenotype.
treatments:
- name: Permanent Pacemaker Implantation
  description: >-
    Pacing is the definitive therapy for symptomatic bradycardia or symptomatic
    pauses; it does not correct the channel defect. In HCN4 carriers the age at
    implantation is later than in SCN5A-related familial sick sinus syndrome,
    and some HCN4 alleles never require a device. Chronotropic pharmacotherapy
    may defer but does not replace it.
  therapeutic_modality: DEVICE
  treatment_term:
    preferred_term: pacemaker implantation
    term:
      id: NCIT:C80434
      label: Pacemaker Placement
  target_mechanisms:
  - target: Sinoatrial Node Automaticity Failure
    treatment_effect: BYPASSES
    description: >-
      An implanted pacemaker substitutes an artificial impulse source for the
      failing sinoatrial node, bypassing rather than repairing the pacemaker
      current defect.
    evidence:
    - reference: PMID:34383451
      reference_title: "Sinus Node Dysfunction."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        First-line treatment for patients with confirmed sinus node dysfunction
        is permanent pacemaker placement with atrial-based pacing and limited
        ventricular pacing when necessary.
      explanation: >-
        Establishes pacing as the first-line intervention against the failing
        sinoatrial node.
  evidence:
  - reference: PMID:28104484
    reference_title: "Sick sinus syndrome with HCN4 mutations shows early onset and frequent association with atrial fibrillation and left ventricular noncompaction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Moreover, HCN4 mutation carriers were more frequently associated with AF
      (43.8%) and LVNC (50%) and with older age at pacemaker implantation
    explanation: >-
      Reports age at pacemaker implantation specifically in HCN4 carriers,
      contrasted with the SCN5A form.
  - reference: PMID:17646576
    reference_title: "Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Despite its critical location, this mutation carries a favorable prognosis
      without the need for pacemaker implantation during long-term follow-up.
    explanation: >-
      Counterpoint that pacing is not required for every HCN4 allele; graded
      PARTIAL because it qualifies rather than supports the indication.
- name: Chronotropic Pharmacotherapy (Cilostazol)
  description: >-
    Cilostazol, a phosphodiesterase-3 inhibitor, raises heart rate in sinus node
    dysfunction and has been used to defer or avoid permanent pacing in
    symptomatic sick sinus syndrome. It is a rate-raising palliative acting
    downstream of the pacemaker-current defect rather than a correction of it,
    and the supporting evidence comes from unselected sick sinus syndrome
    cohorts, not from genotyped HCN4 carriers.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: cilostazol
      term:
        id: CHEBI:31401
        label: cilostazol
  target_mechanisms:
  - target: Sinoatrial Node Automaticity Failure
    treatment_effect: MODULATES
    description: >-
      Cilostazol raises the sinus rate, partially offsetting the depressed
      nodal automaticity without restoring the funny current.
    evidence:
    - reference: PMID:30982679
      reference_title: "Efficacy of cilostazol for sick sinus syndrome to avoid permanent pacemaker implantation: A retrospective case-control study."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Cilostazol was effective for symptomatic SSS to avoid PM implantation by
        increasing HR.
      explanation: >-
        Shows a rate-raising effect on the failing sinoatrial node. Graded
        PARTIAL because the cohort is unselected sick sinus syndrome rather than
        genotyped HCN4 carriers, so the mechanism link is inferred for SSS2.
  evidence:
  - reference: PMID:30982679
    reference_title: "Efficacy of cilostazol for sick sinus syndrome to avoid permanent pacemaker implantation: A retrospective case-control study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The 6-month PM implantation rate was lower in the cilostazol than the
      control group (20.4% vs. 55.8%, respectively; p<0.001).
    explanation: >-
      Quantifies the pacemaker-deferring effect. Graded PARTIAL because this is a
      single-centre retrospective case-control study in unselected sick sinus
      syndrome, not a randomized trial and not HCN4-genotyped.
  - reference: PMID:33017571
    reference_title: "Pharmacologic Approach to Sinoatrial Node Dysfunction."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      This review summarizes the current knowledge about SND mechanisms and
      discusses the possibility of introducing new pharmacologic therapies for
      treating SND.
    explanation: >-
      Frames pharmacologic management of sinoatrial node dysfunction as an area
      of active development rather than established practice; graded PARTIAL
      because it supports the existence of the therapeutic avenue, not the
      efficacy of any particular agent in SSS2.
- name: Avoidance of Bradycardia-Inducing Medications
  description: >-
    Because SSS2 carriers already run a reduced pacemaker current, drugs that
    further depress sinoatrial automaticity or conduction (beta-blockers,
    non-dihydropyridine calcium channel blockers, digoxin, and the selective
    I_f blocker ivabradine, whose molecular target is HCN4 itself) can unmask
    or worsen symptomatic bradycardia. Extrinsic contributors to sinus node
    dysfunction are frequently reversible, so medication review is part of
    management as well as of diagnosis.
  treatment_term:
    preferred_term: supportive care
    term:
      id: NCIT:C15747
      label: Supportive Care
  evidence:
  - reference: PMID:34383451
    reference_title: "Sinus Node Dysfunction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The causes of sinus node dysfunction are intrinsic (e.g., degenerative
      idiopathic fibrosis, cardiac remodeling) or extrinsic (e.g., medications,
      metabolic abnormalities) to the sinoatrial node.
    explanation: >-
      Establishes medications as an extrinsic cause of sinus node dysfunction,
      which is the rationale for avoiding rate-slowing drugs in a carrier.
      Graded PARTIAL because the source addresses sinus node dysfunction
      generally and names no specific agent to avoid in HCN4 carriers.
  - reference: PMID:34383451
    reference_title: "Sinus Node Dysfunction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A diagnosis is made by directly correlating symptoms with a bradyarrhythmia
      and eliminating potentially reversible extrinsic causes.
    explanation: >-
      Supports elimination of reversible extrinsic causes, of which drug therapy
      is the main modifiable one; PARTIAL because the statement is framed as a
      diagnostic rather than therapeutic step.
- name: Genetic Counseling and Cascade Family Screening
  description: >-
    SSS2 is autosomal dominant with variable penetrance, so first-degree
    relatives of a proband carry a 50% prior risk and may be affected while
    entirely asymptomatic. Counselling plus cascade ECG, Holter, echocardiographic
    and HCN4 sequencing of relatives identifies those carriers, which matters
    here because the HCN4 phenotype includes a structural (noncompaction) arm
    that is not detected by rhythm assessment alone.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: genetic counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:17646576
    reference_title: "Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Sixteen members of a family with sinus bradycardia were evaluated.
      Evaluation included a clinical questionnaire, 12-lead ECGs, Holter
      monitoring, echocardiography, and treadmill exercise testing.
    explanation: >-
      Documents the family-wide evaluation protocol by which HCN4 relatives are
      screened, including the echocardiography needed to catch the structural
      arm.
  - reference: PMID:17646576
    reference_title: "Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Eight family members (5 males) were classified as affected. All affected
      family members were asymptomatic with normal exercise capacity during
      long-term follow-up.
    explanation: >-
      Demonstrates the yield of cascade screening in SSS2: half the evaluated
      family was affected and every affected member was asymptomatic, so
      relatives would not have been identified without screening.
differential_diagnoses:
- name: Familial Sick Sinus Syndrome
  description: >-
    The dismech umbrella entry for inherited sinoatrial node dysfunction, which
    spans several causal genes (HCN4, SCN5A, ANK2, LMNA) and both dominant and
    recessive transmission. SSS2 is the HCN4-specific, autosomal dominant member
    of that set and is curated separately because MONDO models it as a distinct
    disease-series-by-gene entity with its own OMIM record.
  disease_term:
    preferred_term: familial sick sinus syndrome
    term:
      id: MONDO:0012061
      label: familial sick sinus syndrome
  distinguishing_features:
  - The umbrella entry is gene-heterogeneous and also spans the autosomal recessive SCN5A form, LMNA and ANK2.
  - SSS2 is defined by a heterozygous HCN4 loss-of-function variant acting on the funny current.
  - Left ventricular noncompaction is a characteristic co-segregating feature of the HCN4 form specifically.
- name: Sick sinus syndrome 1
  description: >-
    The SCN5A-related form of familial sick sinus syndrome, in which
    compound-heterozygous loss-of-function alleles of the cardiac sodium channel
    reduce myocardial excitability.
  disease_term:
    preferred_term: sick sinus syndrome 1
    term:
      id: MONDO:0024562
      label: sick sinus syndrome 1
  distinguishing_features:
  - Recessive rather than dominant transmission.
  - Markedly younger age at diagnosis and at pacemaker implantation than the HCN4 form.
  - Lacks the atrial fibrillation and left ventricular noncompaction burden characteristic of SSS2.
  evidence:
  - reference: PMID:28104484
    reference_title: "Sick sinus syndrome with HCN4 mutations shows early onset and frequent association with atrial fibrillation and left ventricular noncompaction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Meta-analysis of HCN4 mutation carriers showed a significantly younger age
      at diagnosis
    explanation: >-
      Establishes the age-at-diagnosis separation between HCN4 (SSS2), sporadic
      sick sinus syndrome, and SCN5A (SSS1) carriers.
- name: Sinoatrial Block
  description: >-
    Failure of conduction of the sinoatrial impulse out of the node into atrial
    myocardium, producing pauses that on the surface ECG can look like sinus
    arrest.
  disease_term:
    preferred_term: sinoatrial block
    term:
      id: MONDO:0020806
      label: sinoatrial block
  distinguishing_features:
  - Sinoatrial block is a disorder of impulse exit (conduction); SSS2 is a disorder of impulse generation (automaticity).
  - Sinoatrial exit block may also occur within the SSS2 phenotype, so the distinction is mechanistic rather than mutually exclusive.
- name: Sinoatrial Node Dysfunction and Deafness
  description: >-
    An autosomal recessive channelopathy caused by biallelic CACNA1D
    loss-of-function, in which loss of the Cav1.3 L-type calcium current
    produces both sinoatrial node dysfunction and congenital deafness.
  disease_term:
    preferred_term: sinoatrial node dysfunction and deafness
    term:
      id: MONDO:0013960
      label: sinoatrial node dysfunction and deafness
  distinguishing_features:
  - Recessive CACNA1D rather than dominant HCN4.
  - The calcium-current lesion is shared with the cochlear inner hair cell ribbon synapse, so congenital sensorineural deafness accompanies the bradycardia.
  - No left ventricular noncompaction.
- name: Sick sinus syndrome 4
  description: >-
    Familial sinus node and atrioventricular conduction dysfunction caused by
    variation in the G-protein subunit gene GNB2.
  disease_term:
    preferred_term: sick sinus syndrome 4
    term:
      id: MONDO:0859173
      label: sick sinus syndrome 4
  distinguishing_features:
  - The lesion is in G-protein signalling upstream of the pacemaker channels rather than in the channel itself.
  - Atrioventricular conduction disease is a defining rather than incidental component.
notes: >-
  LUMP-VS-SPLIT DECISION. kb/disorders/Familial_Sick_Sinus_Syndrome.yaml
  (MONDO:0012061) already carried an HCN4 pathophysiology node, an HCN4 genetic
  entry, and left ventricular noncompaction as a phenotype. This entry was
  nevertheless curated separately because MONDO:0008102 is a distinct
  disease-series-by-gene entity (is_a MONDO:0012061, RO:0004003 to HGNC:16882,
  xref OMIM:163800) and because the umbrella is deliberately gene-heterogeneous:
  it also spans the autosomal recessive SCN5A form, LMNA, ANK2, and GWAS-level
  susceptibility loci, so its HCN4 content is necessarily a summary. This entry
  adds what the umbrella cannot: the funny-current mechanism at pacemaker-cell
  resolution, the three structural classes of HCN4 allele and their distinct
  biophysical consequences, the separable cAMP-modulation arm that produces
  chronotropic incompetence, two HCN4 mouse models, an in-silico human
  sinoatrial node model, and the quantitative HCN4-specific phenotype
  frequencies (atrial fibrillation 43.8%, noncompaction 50%). The umbrella
  should retain its HCN4 content as the summary view; a follow-up may add
  MONDO:0008102 to it as a has_subtypes term.

  NEC PREFLIGHT. "Sick sinus syndrome 2" sits in a numbered series whose members
  have different causal genes (SSS1 SCN5A, SSS2 HCN4, SSS3 MYH6, SSS4 GNB2),
  a high named-entity-confusion risk class. The MONDO record for MONDO:0008102
  was read directly (runoak -i sqlite:obo:mondo info MONDO:0008102 -O obo) and
  asserts RO:0004003 HGNC:16882 (HCN4) with xref OMIM:163800. `just preflight-dr`
  on the falcon report returned PASS (HCN4 mentioned 91 times, SCN5A 3), and
  every citation used here was independently confirmed to concern HCN4 rather
  than SCN5A, MYH6 or GNB2.

  DEEP RESEARCH. A falcon (Edison) deep-research run was performed
  (research/Sick_Sinus_Syndrome_2_Autosomal_Dominant-deep-research-falcon.md;
  reference_validation reports 8/8 references verified, confabulation_rate 0.0).
  Its narrative was used as a lead only. It cited reviews rather than the
  primary SSS2 literature and its suggested ontology identifiers were largely
  wrong when checked with OAK (for example HP:0005209 and HP:0030247 offered for
  chronotropic incompetence and sinus pause, HP:0012810 for left ventricular
  noncompaction, and NCIT:C15632 offered as "Pacemaker Implantation" when that
  identifier is Chemotherapy). Every ontology term in this entry was therefore
  looked up independently with OAK, and the evidence base was rebuilt from the
  primary pedigree, electrophysiology, and cohort papers.

  GENEREVIEWS. PubMed was searched for a GeneReviews chapter covering sick sinus
  syndrome, sinus node dysfunction, or HCN4 (queries "sick sinus syndrome[TI]
  GeneReviews[TI]", "sinus node dysfunction GeneReviews[All Fields]", "HCN4
  GeneReviews[All Fields]"). No GeneReviews chapter exists for this disorder;
  the hits returned were unrelated chapters (Brugada Syndrome, Heritable
  Thoracic Aortic Disease, Hereditary Transthyretin Amyloidosis), so no
  GeneReviews baseline could be applied.

  TREATMENTS SCOPE. Four treatment entries are curated: pacing (definitive),
  chronotropic pharmacotherapy with cilostazol (pacemaker-deferring), avoidance
  of bradycardia-inducing medications, and genetic counselling with cascade
  family screening. Two management topics raised by the deep-research artifact
  are deliberately NOT curated. (1) Theophylline: the DR describes it as the
  most widely used outpatient drug for sinus node dysfunction, but the claim
  traces to a review rather than to a citable primary study with a quotable
  abstract, and no theophylline trial in sick sinus syndrome could be sourced
  with an exact-quote snippet — per the evidence SOP the claim is dropped rather
  than supported by a manufactured quote. (2) Anticoagulation for the atrial
  fibrillation curated here at FREQUENT: stroke-prevention anticoagulation is
  driven by CHA2DS2-VASc risk and is not specific to, or modified by, the HCN4
  lesion, so it belongs to atrial fibrillation management rather than to the
  SSS2 mechanism graph. Acute in-hospital chronotropes (atropine,
  isoproterenol) are likewise generic bradycardia rescue rather than
  SSS2-specific and are omitted for the same reason.

  IVABRADINE. Ivabradine is a selective I_f (HCN4) blocker used to slow heart
  rate in angina and heart failure. On mechanistic grounds it would be expected
  to aggravate the pacemaker-current deficit in an SSS2 carrier, but no cited
  publication states this for HCN4 carriers specifically, so it is named in the
  "Avoidance of Bradycardia-Inducing Medications" treatment description as a
  mechanistic inference and is not asserted there as an evidenced claim: the
  evidence attached to that entry supports drug-induced sinus node dysfunction
  in general, not ivabradine harm in HCN4 carriers.

  SINOATRIAL EXIT BLOCK. HP:0012723 (Sinoatrial block) exists and is a
  descendant of the HP:0011702 term used for the pause/arrest phenotype, and
  exit block appears in the general sick-sinus-syndrome ECG criteria quoted
  here. It is not curated as a separate phenotype because no HCN4-specific
  source in the cached references reports it in genotyped carriers; adding it
  would assert a genotype-phenotype link the evidence does not carry.

  PREVALENCE. No population prevalence estimate specific to SSS2 could be
  sourced, so no prevalence record is asserted. The per-gene case fraction
  (2 of 38 familial SSS families) is recorded under genetic.case_fractions,
  which is the correct slot for a genetic-spectrum share rather than a
  population rate.

📚

References & Deep Research

Deep Research

1

Falcon ▸

1. Disease Information

Edison Scientific Literature 30 citations 2026-08-17T09:19:56.317302

1. Disease Information

Disease Overview

Sick Sinus Syndrome 2 (SSS2), Autosomal Dominant, is a hereditary cardiac arrhythmia disorder characterized by intrinsic dysfunction of the sinoatrial node (SAN), the heart's primary pacemaker. The disease manifests as the heart's inability to perform adequate pacemaking function, resulting in a spectrum of cardiac rhythm disturbances including symptomatic sinus bradycardia, chronotropic incompetence, sinoatrial block, sinus arrest, and paroxysmal supraventricular tachyarrhythmias (erlenhardt2020diseaseassociatedhcn4v759i pages 1-2, tytgat2022reviewhcnchannels pages 5-6).

Key Identifiers

While specific OMIM identifiers for "Sick Sinus Syndrome 2" were not retrieved in the current literature search, the disease is associated with mutations in the HCN4 gene. The condition falls under the broader category of sinus node dysfunction (SND) and familial sick sinus syndrome (tytgat2022reviewhcnchannels pages 5-6, tytgat2022reviewhcnchannels pages 6-7).

OMIM: Related entries include HCN4 gene (OMIM 605206) and familial sinus bradycardia phenotypes
Alternative Names: Sinus Node Dysfunction (SND), Familial Sick Sinus Syndrome, Familial Sinus Bradycardia
Disease Category*: Mendelian inherited arrhythmia syndrome, primary electrical disorder

Information Source Type

The information in this report is derived from aggregated disease-level resources including peer-reviewed scientific literature, genetic databases, and preclinical model organism studies. It represents disease-level knowledge rather than individual patient data (erlenhardt2020diseaseassociatedhcn4v759i pages 1-2, zheng2023emergingsignalingregulation pages 1-3).

2. Etiology

Disease Causal Factors

Primary Genetic Cause: Sick Sinus Syndrome 2 is primarily caused by heterozygous pathogenic variants in the HCN4 gene (hyperpolarization-activated cyclic nucleotide-gated channel 4), which encodes the cardiac pacemaker channel conducting the hyperpolarization-activated cation current (If), essential for pacemaker activity (erlenhardt2020diseaseassociatedhcn4v759i pages 1-2, tytgat2022reviewhcnchannels pages 5-6). The HCN4 channel is the predominant HCN isoform expressed in the mammalian sinoatrial node and is critical for generating spontaneous pacemaker potentials (maarel2023geneticsofsinoatrial pages 2-3).

Risk Factors

Genetic Risk Factors: - HCN4 Mutations: At least 22 HCN4 mutations or variants have been identified in association with sinus node dysfunction, with 13 showing clear genotype-phenotype associations (tytgat2022reviewhcnchannels pages 5-6). Most pathogenic variants are heterozygous loss-of-function (LOF) mutations that act through dominant-negative mechanisms with variable penetrance (tytgat2022reviewhcnchannels pages 6-7). - Variant Types: Pathogenic variants include missense mutations (e.g., R550H, E1193Q, R378C, G482R, V492F, P883R) and truncating mutations (e.g., 695X) affecting channel activation, cAMP sensitivity, membrane trafficking, or current density (tytgat2022reviewhcnchannels pages 6-7).

Environmental Risk Factors: - Age: Aging is a major risk factor, with age-related SAN degeneration representing the most common intrinsic cause of sinus node dysfunction (mesirca2021pharmacologicapproachto pages 8-9, iop2021inheritedandacquired pages 8-9, zheng2023emergingsignalingregulation pages 1-3). Reduced expression of proteins essential for current generation during aging correlates with increased SSS diagnosis in elderly patients (iop2021inheritedandacquired pages 8-9). - Endurance Athletic Training: Associated with increased bradyarrhythmia risk through both increased vagal input (hypervagotonia) and intrinsic ion channel remodeling (mesirca2021pharmacologicapproachto pages 8-9). - Medications: Certain pharmacological agents cause cardiac toxicity targeting the SAN, including calcium antagonists (verapamil, diltiazem) and sodium channel blockers (propafenone), which can induce or worsen SSS (iop2021inheritedandacquired pages 9-10). - Metabolic Disorders: Diabetes mellitus is a significant risk factor causing downregulated electrical signaling, oxidative stress, inflammation, atrial fibrosis, and decreased HCN4 expression in the SAN (iop2021inheritedandacquired pages 9-10, iop2021inheritedandacquired pages 14-14). - Cardiovascular Disease: Myocardial ischemia/infarction, heart failure, coronary artery disease, and atrial fibrillation can lead to secondary SND through oxidative stress, calcium overload, and inflammatory mechanisms (mesirca2021pharmacologicapproachto pages 8-9, iop2021inheritedandacquired pages 8-9, iop2021inheritedandacquired pages 9-10).

Protective Factors

No specific genetic or environmental protective factors have been identified in the available literature for HCN4-related sick sinus syndrome.

Gene-Environment Interactions

The phenotypic expression of HCN4 mutations shows significant modulation by environmental factors. Hypoxia, oxidative stress from cardiovascular diseases, inflammatory conditions, and metabolic derangements can exacerbate the functional consequences of HCN4 variants (iop2021inheritedandacquired pages 8-9, iop2021inheritedandacquired pages 9-10). Vagal tone variability may explain incomplete penetrance in some mutation carriers who remain asymptomatic despite carrying pathogenic variants (iop2021inheritedandacquired pages 6-8).

3. Phenotypes

The clinical phenotypes of Sick Sinus Syndrome 2 are summarized in detail below and in the accompanying table (artifact-02).

Core Cardiac Phenotypes

Sinus Bradycardia (HP:0001662 Bradycardia) - Type: Clinical sign, electrophysiological abnormality - Characteristics: Resting heart rates can be markedly reduced (e.g., 37 bpm documented in adult patient, ~40% reduction in embryonic mouse models) (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5, hennis2022paradigmshiftnew pages 2-4) - Onset: Variable; can present from early life in familial cases or later in adulthood - Severity: Mild to severe - Frequency: Core phenotype, very common in HCN4-related disease - Progression: Often progressive with age - Quality of Life Impact: Causes fatigue, exercise intolerance, dizziness, and syncope

Chronotropic Incompetence (HP:0005209 Chronotropic incompetence) - Type: Clinical sign, functional abnormality - Characteristics: Failure to achieve age-appropriate maximum heart rate during exercise (e.g., 146 bpm versus predicted 90-110% range in documented case); impaired β-adrenergic responsiveness (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5, hennis2022paradigmshiftnew pages 8-10) - Onset: Recognized during exercise testing or stress - Severity: Moderate to severe - Frequency: Common in HCN4-related SND - Progression: Stable or progressive - Quality of Life Impact: Severe exercise limitation, reduced functional capacity

Sinus Pauses (HP:0030247 Sinus pause) - Type: Electrophysiological abnormality - Characteristics: Pauses exceeding 2-3 seconds; documented up to 3 seconds in human cases; recurrent pauses are hallmark of reduced HCN4 function (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5, tytgat2022reviewhcnchannels pages 5-6) - Onset: Variable, often recognized during continuous ECG monitoring - Severity: Moderate to severe - Frequency: Common in experimental models and human cases - Quality of Life Impact: Presyncope, syncope, risk of falls

Sinus Arrest (HP:0011706 Sinus arrest) - Type: Severe electrophysiological abnormality - Characteristics: Complete failure of SAN impulse generation (erlenhardt2020diseaseassociatedhcn4v759i pages 1-2, maarel2023geneticsofsinoatrial pages 1-2) - Severity: Severe - Quality of Life Impact: Life-threatening; requires pacemaker intervention

Sinoatrial Block (HP:0011710 Sinoatrial block) - Type: Conduction abnormality - Characteristics: Impaired impulse transmission from SAN to atrium despite preserved SAN automaticity (tytgat2022reviewhcnchannels pages 5-6, zheng2023emergingsignalingregulation pages 1-3) - Severity: Mild to severe

Sinus Dysrhythmia (HP:0011708 Cardiac dysrhythmia) - Type: Clinical sign - Characteristics: Large beat-to-beat variability and unstable pacemaker output; severe sinus dysrhythmia described in HCN4FEA mice (hennis2022paradigmshiftnew pages 8-10, hennis2021discoveryofa pages 76-80) - Severity: Mild to severe

Associated Arrhythmias

Atrial Fibrillation (HP:0005110 Atrial fibrillation) - Type: Secondary arrhythmia - Characteristics: Increased susceptibility with HCN4-related SND; may coexist in bradycardia-tachycardia syndrome (tytgat2022reviewhcnchannels pages 6-7, maarel2023geneticsofsinoatrial pages 1-2) - Frequency: Variable expressivity, not universal - Severity: Moderate to severe - Quality of Life Impact: Embolic risk, cardiomyopathy complications

Supraventricular Tachyarrhythmias (HP:0005117 Supraventricular tachycardia) - Type: Paroxysmal arrhythmia - Characteristics: Part of bradycardia-tachycardia syndrome spectrum (erlenhardt2020diseaseassociatedhcn4v759i pages 1-2, zheng2023emergingsignalingregulation pages 1-3)

Structural Cardiac Abnormalities

Left Ventricular Noncompaction Cardiomyopathy (HP:0012810 Left ventricular noncompaction) - Type: Structural abnormality - Characteristics: Excessive ventricular trabeculation/hypertrabeculation with risk of heart failure, arrhythmias, and thromboembolic complications (tytgat2022reviewhcnchannels pages 6-7) - Frequency: Reported in subset of HCN4 mutation carriers; variable expressivity - Severity: Moderate to severe

Symptoms

Dizziness/Presyncope (HP:0002321 Vertigo or HP:0001288 Lightheadedness) - Type: Symptom - Characteristics: Accompanies marked sinus bradycardia; documented case presented with dizziness and nausea (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5) - Severity: Mild to moderate - Quality of Life Impact: Affects daily activities, risk of injury from falls

Clinical Interventions Required

Pacemaker Requirement (HP:0005304 Cardiac pacemaker implantation) - Type: Therapeutic intervention necessity - Characteristics: Permanent pacing is definitive treatment for chronic symptomatic SND (mesirca2021pharmacologicapproachto pages 1-2, erlenhardt2020diseaseassociatedhcn4v759i pages 4-5) - Frequency: Common in clinically significant symptomatic cases - Onset: Often adulthood when symptoms become intolerable - Quality of Life Impact: Improves symptoms but requires device management

Phenotype name	HPO term suggestion	Frequency / penetrance	Age of onset	Severity	Key clinical characteristics
Sinus bradycardia	HP:0001662 Bradycardia	Very common/core phenotype in HCN4-related disease; human HCN4 literature summarized 22 variants linked to SND, with 13 showing clear genotype-phenotype association; penetrance is variable and often incomplete in heterozygous families (tytgat2022reviewhcnchannels pages 5-6, tytgat2022reviewhcnchannels pages 6-7)	Variable; can present in embryonic life in models, childhood/young adulthood in familial cases, or adulthood; symptomatic case described at age 49 years (maarel2023geneticsofsinoatrial pages 2-3, erlenhardt2020diseaseassociatedhcn4v759i pages 4-5)	Mild to severe	Resting sinus rates can be markedly reduced; example patient had 37 bpm, and animal models show severe intrinsic SAN slowing (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5, hennis2022paradigmshiftnew pages 8-10)
Chronotropic incompetence	HP:0005209 Chronotropic incompetence	Common in SAN dysfunction due to HCN4 dysregulation, but exact human penetrance not well quantified (hennis2022paradigmshiftnew pages 8-10, tytgat2022reviewhcnchannels pages 5-6)	Usually recognized when exercise or autonomic challenge fails to raise heart rate appropriately; adult case documented (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5)	Moderate to severe	Failure to achieve expected heart-rate increase during exercise or stress; reflects impaired autonomic/SAN responsiveness (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5, hennis2022paradigmshiftnew pages 8-10)
Sinus pauses	HP:0030247 Sinus pause	Common in experimental models and reported in human cases; exact penetrance unknown (tytgat2022reviewhcnchannels pages 5-6, mesirca2021pharmacologicapproachto pages 6-8)	Variable; can occur in adult symptomatic disease and in inducible/conditional mouse models (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5, mesirca2021pharmacologicapproachto pages 6-8)	Moderate to severe	Pauses may exceed 2-3 seconds; example Holter showed pauses up to 3 seconds; recurrent pauses are a hallmark of reduced HCN4 function (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5, tytgat2022reviewhcnchannels pages 5-6)
Sinus arrest	HP:0011706 Sinus arrest	Reported as part of the SND spectrum; frequency not well quantified for HCN4 specifically (erlenhardt2020diseaseassociatedhcn4v759i pages 1-2, maarel2023geneticsofsinoatrial pages 1-2)	Variable	Severe	Represents failure of impulse generation by the SAN; contributes to dizziness, presyncope/syncope, and pacemaker requirement (erlenhardt2020diseaseassociatedhcn4v759i pages 1-2, maarel2023geneticsofsinoatrial pages 1-2)
Sinoatrial exit block / impaired impulse transmission	HP:0011710 Sinoatrial block	Recognized component of SND/SSS spectrum; specific HCN4 penetrance not quantified (tytgat2022reviewhcnchannels pages 5-6, zheng2023emergingsignalingregulation pages 1-3)	Variable	Mild to severe	SAN automaticity may be preserved but conduction from SAN to atrium is impaired; part of intrinsic SAN inadequacy definition (tytgat2022reviewhcnchannels pages 5-6, zheng2023emergingsignalingregulation pages 1-3)
Sinus dysrhythmia / irregular sinus rhythm	HP:0011708 Cardiac dysrhythmia	Prominent in HCN4 mouse models and likely relevant to human disease; exact human frequency unknown (hennis2022paradigmshiftnew pages 8-10, hennis2022paradigmshiftnew pages 5-6)	Variable	Mild to severe	Large beat-to-beat variability and unstable pacemaker output; severe sinus dysrhythmia described in HCN4FEA mice (hennis2022paradigmshiftnew pages 8-10, hennis2021discoveryofa pages 76-80)
Atrial fibrillation	HP:0005110 Atrial fibrillation	Increased susceptibility reported with HCN4-related SND, but not universal; variable expressivity (tytgat2022reviewhcnchannels pages 6-7, maarel2023geneticsofsinoatrial pages 1-2)	Usually later than isolated bradycardia; variable	Moderate to severe	May coexist with bradycardia/tachycardia syndrome; can contribute to embolic risk and cardiomyopathy (tytgat2022reviewhcnchannels pages 6-7, maarel2023geneticsofsinoatrial pages 1-2)
Paroxysmal supraventricular tachyarrhythmia / tachy-brady syndrome	HP:0005117 Supraventricular tachycardia	Part of the broader SSS phenotype spectrum; exact penetrance not established (erlenhardt2020diseaseassociatedhcn4v759i pages 1-2, zheng2023emergingsignalingregulation pages 1-3)	Variable	Moderate	Alternation of slow and fast atrial rhythms is characteristic of sick sinus syndrome and may complicate management (erlenhardt2020diseaseassociatedhcn4v759i pages 1-2, zheng2023emergingsignalingregulation pages 1-3)
Dizziness / presyncope	HP:0002321 Vertigo or HP:0001288 Lightheadedness	Symptomatic manifestation rather than core electrophysiologic trait; frequency depends on bradycardia severity (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5)	Typically when clinically manifest disease develops	Mild to moderate	Example patient presented with dizziness and nausea accompanying marked sinus bradycardia (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5)
Pacemaker requirement	HP:0005304 Cardiac pacemaker implantation	Common in clinically significant symptomatic SND; exact percentage for HCN4 families unavailable (mesirca2021pharmacologicapproachto pages 1-2, erlenhardt2020diseaseassociatedhcn4v759i pages 4-5)	Often adulthood, when symptomatic bradycardia/pauses become clinically significant	Severe disease indicator	Permanent pacing is the definitive treatment for chronic symptomatic SND and reflects advanced functional impact (mesirca2021pharmacologicapproachto pages 1-2, erlenhardt2020diseaseassociatedhcn4v759i pages 4-5)
Left ventricular noncompaction cardiomyopathy	HP:0012810 Left ventricular noncompaction	Reported in a subset of HCN4 mutation carriers; variable expressivity and not present in all families (tytgat2022reviewhcnchannels pages 6-7)	Variable; may be recognized with cardiac imaging after arrhythmia workup	Moderate to severe	Excessive ventricular trabeculation/hypertrabeculation; may be accompanied by heart failure, arrhythmias, and thromboembolic risk (tytgat2022reviewhcnchannels pages 6-7)
Heart failure / cardiomyopathy complications	HP:0001635 Congestive heart failure	Secondary/less common manifestation, particularly when structural cardiomyopathy co-occurs (tytgat2022reviewhcnchannels pages 6-7)	Usually later/complication stage	Severe	Seen mainly in mutation carriers with associated noncompaction or tachycardia-induced cardiomyopathy rather than isolated sinus node dysfunction (tytgat2022reviewhcnchannels pages 6-7)

Table: This table summarizes the principal clinical manifestations reported for HCN4-related sick sinus syndrome 2, including suggested HPO terms and practical notes on onset, severity, and penetrance. It is useful for phenotype curation and disease knowledge base population.

4. Genetic/Molecular Information

Causal Genes

HCN4 Gene (Hyperpolarization-Activated Cyclic Nucleotide-Gated Channel 4) - Gene Symbol: HCN4 - HGNC ID: HGNC:16882 - OMIM Gene ID: 605206 - Chromosomal Location: 15q24-q25 - Gene Function*: Encodes the predominant cardiac pacemaker channel conducting the If current, essential for spontaneous rhythmic activity of sinoatrial node pacemaker cells (erlenhardt2020diseaseassociatedhcn4v759i pages 1-2, maarel2023geneticsofsinoatrial pages 2-3)

Pathogenic Variants

A comprehensive table of HCN4 pathogenic variants is provided (artifact-00). Key variants include:

Loss-of-Function Variants (Most Common): - p.R550H: Missense variant causing LOF through mechanisms consistent with dominant-negative effects (tytgat2022reviewhcnchannels pages 6-7) - p.E1193Q: Distal C-terminus missense variant causing LOF (tytgat2022reviewhcnchannels pages 6-7) - p.R378C: Missense variant with leftward/negative shift in activation curve (tytgat2022reviewhcnchannels pages 6-7) - p.G482R: Pore domain missense variant causing LOF (tytgat2022reviewhcnchannels pages 6-7) - p.V492F: S6 helix missense variant in highly conserved region causing LOF (tytgat2022reviewhcnchannels pages 6-7, tytgat2022reviewhcnchannels pages 11-12) - p.695X: Truncating nonsense mutation causing LOF (tytgat2022reviewhcnchannels pages 6-7)

Gain-of-Function Variants (Rare): - p.P883R: Exceptional GOF variant showing positive voltage shift and faster deactivation (tytgat2022reviewhcnchannels pages 6-7) - p.R524Q: GOF variant with enhanced cAMP sensitivity associated with familial inappropriate sinus tachycardia (tytgat2022reviewhcnchannels pages 6-7)

Variant of Uncertain Significance: - p.V759I (c.2275G>A): Initially classified as likely pathogenic, but detailed functional studies showed no demonstrable abnormality; likely insufficient alone to cause disease (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5, erlenhardt2020diseaseassociatedhcn4v759i pages 1-2)

Variant Classification and Functional Consequences

Mechanism of LOF: - Negative shifts in voltage-dependent activation curves - Reduced membrane expression density - Decreased current density - Altered cAMP sensitivity - Defective channel trafficking to cell membrane - Impaired interaction with regulatory proteins (tytgat2022reviewhcnchannels pages 6-7)

Dominant-Negative Effects: Most SND-associated HCN4 mutations are heterozygous and act through dominant-negative mechanisms, where mutant subunits co-assemble with wild-type subunits in heterotetrameric channels, impairing overall channel function (tytgat2022reviewhcnchannels pages 6-7).

Allele Frequency

The V759I variant occurs at ~0.6% frequency in European populations, suggesting it may be a benign polymorphism rather than a pathogenic variant (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5). Most pathogenic HCN4 variants are rare or private mutations within families.

Somatic vs Germline

All reported HCN4 mutations causing familial sick sinus syndrome are germline variants inherited in an autosomal dominant pattern (tytgat2022reviewhcnchannels pages 6-7).

Variant (protein; genomic if available)	Variant class	Functional consequence	Protein location/domain	Reported phenotype(s)	Notes	Citation
p.R378C	Missense	Loss-of-function; leftward/negative shift in activation reported for SND-associated variants	Transmembrane/channel region (exact subdomain not specified in available evidence)	Sinus node dysfunction / sick sinus syndrome, bradycardia	Listed among HCN4 variants with clear SND association	(tytgat2022reviewhcnchannels pages 6-7)
p.G482R	Missense	Loss-of-function	Pore domain	Sinus node dysfunction / sick sinus syndrome, bradycardia	Pore-domain variant highlighted among pathogenic SND variants	(tytgat2022reviewhcnchannels pages 6-7)
p.V492F	Missense	Loss-of-function	S6 helix, highly conserved region	Sinus node dysfunction / sick sinus syndrome, bradycardia	Conserved S6 localization supports functional importance	(tytgat2022reviewhcnchannels pages 6-7, tytgat2022reviewhcnchannels pages 11-12)
p.R524Q	Missense	Gain-of-function; enhanced cAMP sensitivity	C-linker/CNBD-proximal region (exact domain not specified in available evidence)	Familial inappropriate sinus tachycardia; sinus node dysfunction spectrum	Not a classic bradycardic SSS allele, but relevant HCN4 SND-spectrum variant	(tytgat2022reviewhcnchannels pages 6-7)
p.R550H	Missense	Loss-of-function; dominant-negative pattern described for most SND alleles	C-terminal cytoplasmic region (exact domain not specified in available evidence)	Sinus node dysfunction / sick sinus syndrome, bradycardia	One of the recurrent heterozygous SND-associated HCN4 variants	(tytgat2022reviewhcnchannels pages 6-7)
p.695X	Truncating / nonsense	Loss-of-function	Truncation of C-terminal channel region	Sinus node dysfunction / sick sinus syndrome, bradycardia	Premature stop expected to impair channel function	(tytgat2022reviewhcnchannels pages 6-7)
p.V759I; c.2275G>A	Missense	No demonstrable abnormality in available functional assays; likely benign/insufficient alone	Distal C-terminal region, exon 8	Symptomatic sinus bradycardia, chronotropic incompetence, sinus pauses in reported carrier	Initially considered likely pathogenic in a family-history context, but functional testing did not support causality	(erlenhardt2020diseaseassociatedhcn4v759i pages 4-5, erlenhardt2020diseaseassociatedhcn4v759i pages 1-2)
p.P883R	Missense	Gain-of-function; positive voltage shift and faster deactivation	Distal C-terminus	Sinus node dysfunction spectrum	Exceptional because most HCN4 SND variants are loss-of-function	(tytgat2022reviewhcnchannels pages 6-7)
p.E1193Q	Missense	Loss-of-function	Distal C-terminus	Sinus node dysfunction / sick sinus syndrome, bradycardia	Distal C-terminal SND-associated variant	(tytgat2022reviewhcnchannels pages 6-7)
HCN4 SND-associated variants overall	Mostly missense, occasional truncating	Predominantly heterozygous dominant-negative loss-of-function via negative activation shift, reduced membrane expression, decreased current density, altered cAMP sensitivity, or trafficking defects	Frequently transmembrane/pore/C-terminal regulatory regions	Sinus bradycardia, sinus pauses/arrest, chronotropic incompetence, atrial fibrillation susceptibility; sometimes noncompaction cardiomyopathy	Review identified 22 reported HCN4 SND variants, with 13 considered to have clear genotype-phenotype association	(tytgat2022reviewhcnchannels pages 5-6, tytgat2022reviewhcnchannels pages 6-7)

Table: This table summarizes key HCN4 variants discussed in the available evidence for Sick Sinus Syndrome 2 and related sinus node dysfunction phenotypes. It highlights variant class, inferred functional effect, domain context, and clinical manifestations to support genotype-phenotype interpretation.

5. Environmental Information

Environmental Factors

Cardiac Toxins: Calcium antagonists (verapamil, diltiazem), sodium channel blockers (propafenone) (iop2021inheritedandacquired pages 9-10)
Ischemia/Hypoxia: Myocardial ischemia, oxidative stress (iop2021inheritedandacquired pages 8-9, iop2021inheritedandacquired pages 9-10)
Inflammatory Conditions: Systemic inflammation affecting cardiac tissue (iop2021inheritedandacquired pages 8-9)

Lifestyle Factors

Endurance Athletic Training: Associated with increased vagal tone and ion channel remodeling (mesirca2021pharmacologicapproachto pages 8-9)
Age: Progressive age-related degeneration (mesirca2021pharmacologicapproachto pages 8-9, iop2021inheritedandacquired pages 8-9)

Infectious Agents

Not applicable. While infectious diseases can contribute to secondary SAN dysfunction, no specific infectious agents are primary causes of the inherited HCN4-related disease.

6. Mechanism / Pathophysiology

Molecular Pathways

HCN4 Channel Function and Regulation: HCN4 channels are activated by membrane hyperpolarization and directly modulated by cyclic nucleotides (cAMP), which shift voltage-dependent activation toward more depolarized potentials (tytgat2022reviewhcnchannels pages 4-5, hennis2022paradigmshiftnew pages 5-6). The channels generate 70-80% of the total sinoatrial If current across vertebrate species (tytgat2022reviewhcnchannels pages 5-6). cAMP binding to the cyclic nucleotide-binding domain (CNBD) induces conformational changes that propagate to the pore, causing gate-forming inner helices to rotate open and increasing channel availability at physiological voltages (tytgat2022reviewhcnchannels pages 4-5).

Regulatory Mechanisms: - Phosphoinositides (PIP2): Stabilize voltage sensor and shift HCN4 activation toward depolarizing potentials (tytgat2022reviewhcnchannels pages 4-5) - Cholesterol: Modulates HCN4 localization and channel kinetics (tytgat2022reviewhcnchannels pages 4-5) - SGO1 (Shugoshin-1): Maintains cardiac automaticity by regulating HCN4 surface expression (tytgat2022reviewhcnchannels pages 4-5, tytgat2022reviewhcnchannels pages 11-12) - Src Tyrosine Kinase: Regulates HCN4 gating through direct binding and phosphorylation at Tyr531 (tytgat2022reviewhcnchannels pages 11-12)

Cellular Processes

Pacemaker Cell Automaticity: The sinoatrial node comprises specialized pacemaker cardiomyocytes that spontaneously oscillate their membrane potential through integrated "membrane clock" and "calcium clock" mechanisms (maarel2023geneticsofsinoatrial pages 1-2). HCN4 channels contribute to the diastolic depolarization phase of the pacemaker potential, progressively depolarizing the membrane toward the threshold for voltage-gated calcium channel activation and action potential firing (tytgat2022reviewhcnchannels pages 5-6, erlenhardt2020diseaseassociatedhcn4v759i pages 1-2).

Firing vs Nonfiring Modes: Recent studies reveal that HCN4 cAMP-dependent regulation controls the balance between firing and nonfiring pacemaker cells in the SAN network (hennis2022paradigmshiftnew pages 5-6, hennis2022paradigmshiftnew pages 8-10). Loss of HCN4 cyclic nucleotide-dependent regulation leads to excessive nonfiring pacemaker cells, causing severe bradycardia and sinus dysrhythmia (hennis2022paradigmshiftnew pages 8-10). The mechanism involves dynamic mode shifts and hysteresis—a history-dependent process where HCN4 voltage-dependent activation depends on the holding membrane potential (hennis2022paradigmshiftnew pages 5-6).

Protein Dysfunction

Loss-of-Function Mechanisms: HCN4 mutations impair channel function through: 1. Altered voltage-dependent gating (negative activation shifts reduce channel availability at physiological potentials) 2. Reduced membrane trafficking and surface expression 3. Decreased current amplitude 4. Impaired cAMP sensitivity (inability to respond to β-adrenergic stimulation) 5. Dominant-negative suppression of wild-type channel function in heterotetrameric complexes (tytgat2022reviewhcnchannels pages 6-7)

Gain-of-Function Mechanisms (Rare): Some variants cause positive voltage shifts and enhanced cAMP sensitivity, leading to inappropriate sinus tachycardia rather than bradycardia (tytgat2022reviewhcnchannels pages 6-7).

Causal Chain: From Genetic Mutation to Clinical Manifestation

Upstream Events: 1. Germline HCN4 mutation → Altered channel protein structure 2. Impaired channel trafficking/assembly → Reduced functional channel density at cell membrane 3. Abnormal voltage-dependent gating → Reduced If current during diastolic depolarization

Intermediate Events: 4. Slowed or unstable diastolic depolarization in SAN pacemaker cells 5. Increased proportion of nonfiring pacemaker cells in SAN network 6. Reduced intrinsic heart rate and impaired chronotropic responsiveness 7. Unstable pacemaker leadership within SAN causing dysrhythmia

Downstream Events: 8. Symptomatic sinus bradycardia, pauses, arrest 9. Compensatory arrhythmias (atrial fibrillation, junctional escape rhythms) 10. Hemodynamic consequences (cerebral hypoperfusion, exercise intolerance) 11. Clinical symptoms (dizziness, syncope, fatigue) → Pacemaker requirement

Cell Types Involved

Sinoatrial Node Pacemaker Cells (CL:0002072 pacemaker cell of sinoatrial node): Primary affected cell type
Cardiac Myocytes (CL:0000746 cardiac muscle cell): Working myocardium depends on SAN pacing
Fibroblasts (CL:0000057 fibroblast): Component of SAN microenvironment (zheng2023emergingsignalingregulation pages 1-3, mesirca2021pharmacologicapproachto pages 16-17)

Biological Processes (GO Terms)

GO:0086091 - regulation of heart rate by cardiac conduction
GO:0086015 - SA node cell action potential
GO:0086019 - cell-cell signaling involved in cardiac conduction
GO:0060371 - regulation of atrial cardiac muscle cell membrane depolarization
GO:0086001 - cardiac muscle cell action potential
GO:0003015 - heart process
GO:0034765 - regulation of ion transmembrane transport

7. Anatomical Structures Affected

Organ Level

Primary Organ: Heart (UBERON:0000948) - Sinoatrial Node (UBERON:0002049): Primary site of dysfunction; located at junction of superior vena cava and right atrium; dimensions in humans: 11-30 mm length, 2-6 mm width, 2.2-2.6 mm thickness (maarel2023geneticsofsinoatrial pages 1-2, zheng2023emergingsignalingregulation pages 1-3) - Right Atrium (UBERON:0002078): Receives electrical impulse from SAN - Cardiac Conduction System (UBERON:0002350): Network of specialized tissues distributing depolarizing currents (maarel2023geneticsofsinoatrial pages 1-2)

Secondary Organ Involvement: - Brain: Cerebral hypoperfusion from bradycardia - Kidneys, Other Organs: Insufficient perfusion in severe cases (erlenhardt2020diseaseassociatedhcn4v759i pages 1-2)

Body Systems: - Cardiovascular System (UBERON:0004535): Primary system affected - Nervous System: Secondary effects from hypoperfusion

Tissue and Cell Level

Tissue Types: - Cardiac Pacemaker Tissue: Specialized nodal tissue with unique electrophysiological properties distinct from working myocardium (maarel2023geneticsofsinoatrial pages 1-2, zheng2023emergingsignalingregulation pages 1-3) - Fibrous Connective Tissue: SAN pacemaker cells are embedded within fibrous connective tissue matrix composed primarily of collagen and elastin (zheng2023emergingsignalingregulation pages 1-3)

Specific Cell Populations: - Pacemaker Cells (CL:0002072): Generate spontaneous action potentials; express high levels of HCN4 (maarel2023geneticsofsinoatrial pages 2-3, zheng2023emergingsignalingregulation pages 1-3) - Transitional Cells: Cells between SAN and working atrial myocardium - Supporting Cells: Fibroblasts, endothelial cells, neurons, macrophages within SAN microenvironment (zheng2023emergingsignalingregulation pages 1-3)

Subcellular Level (GO Cellular Component Terms)

GO:0016020 - membrane (HCN4 channel localization)
GO:0005886 - plasma membrane (functional channel location)
GO:0034705 - potassium channel complex (HCN4 tetrameric assembly)
GO:0016021 - integral component of membrane

Localization

Anatomical Site: Sinoatrial node at right atrium-superior vena cava junction (UBERON:0002049)
Lateralization: Right-sided (sinoatrial node is right atrial structure)

8. Temporal Development

Onset

Age of Onset: - Embryonic/Developmental: HCN4 is essential for embryonic pacemaker development; complete loss causes embryonic lethality at E9.5-E11.5 in mice (maarel2023geneticsofsinoatrial pages 2-3, tytgat2022reviewhcnchannels pages 5-6, mesirca2021pharmacologicapproachto pages 6-8) - Pediatric/Young Adult: Familial cases can present in childhood or young adulthood (documented case at age 49 years with family history) (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5) - Adult-Onset: Many patients develop symptoms in adulthood; symptom onset correlates with age-related SAN degeneration and accumulated effects of incomplete penetrance (mesirca2021pharmacologicapproachto pages 8-9, iop2021inheritedandacquired pages 8-9)

Onset Pattern: - Insidious/Chronic: Most cases show gradual progression rather than acute onset - Variable Expressivity: Within families, onset age and severity vary significantly due to incomplete penetrance (tytgat2022reviewhcnchannels pages 6-7)

Progression

Disease Course: - Progressive: Often shows progressive worsening with age (mesirca2021pharmacologicapproachto pages 8-9, iop2021inheritedandacquired pages 8-9) - Stable Periods: Some patients have prolonged stable periods before decompensation - Episodic: Paroxysmal symptoms (dizziness, presyncope) triggered by bradycardia or pauses

Disease Duration: - Chronic Lifelong: Once manifest, requires lifelong management; pacemaker therapy provides symptomatic control but not cure (mesirca2021pharmacologicapproachto pages 1-2)

Critical Periods

Embryonic Development: HCN4 expression initiated during heart tube elongation; essential for mature pacemaker cell formation (maarel2023geneticsofsinoatrial pages 2-3, tytgat2022reviewhcnchannels pages 5-6)
Exercise/Stress: Chronotropic incompetence becomes apparent during physiological demands (hennis2022paradigmshiftnew pages 8-10, erlenhardt2020diseaseassociatedhcn4v759i pages 4-5)

9. Inheritance and Population

Inheritance Pattern

Autosomal Dominant with incomplete penetrance and variable expressivity (tytgat2022reviewhcnchannels pages 6-7)

Penetrance: - Incomplete penetrance is common; not all mutation carriers develop symptomatic disease (tytgat2022reviewhcnchannels pages 6-7) - Penetrance may be age-dependent, with increased symptom manifestation in older individuals

Expressivity: - Variable expressivity within families; mutation carriers can range from asymptomatic to severely symptomatic requiring pacemaker (tytgat2022reviewhcnchannels pages 6-7)

Genetic Heterogeneity: - Multiple different HCN4 mutations can cause similar phenotypes - Other genes (SCN5A, CACNA1D, etc.) can cause overlapping sick sinus syndrome phenotypes (liang2023casereportscn5a pages 1-3)

Epidemiology

Prevalence and Incidence: Specific prevalence and incidence data for HCN4-related familial sick sinus syndrome are not available in the retrieved literature. Familial isolated sinus bradycardia is described as uncommon (liang2023casereportscn5a pages 1-3). Sick sinus syndrome in general increases with aging and is expected to increase in incidence over the next 50 years due to population aging (mesirca2021pharmacologicapproachto pages 1-2).

Population Demographics

Sex Ratio: No specific sex bias is documented for HCN4-related disease in the available literature, though sex-related differences in arrhythmia phenotypes are recognized generally (tytgat2022reviewhcnchannels pages 6-7).

Geographic/Ethnic Distribution: No specific founder effects or population-specific variants are documented in the reviewed literature for HCN4-related SSS2. The V759I variant has ~0.6% frequency in European populations (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5).

10. Diagnostics

Clinical Tests

Electrocardiography (ECG): - Resting ECG: Documents sinus bradycardia (e.g., 37 bpm); normal PR, QRS, and QT intervals typical unless conduction defects coexist (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5) - 24-Hour Holter Monitoring: Captures heart rate variability (e.g., 27-117 bpm), sinus pauses (up to 3 seconds), bradycardia-related arrhythmias (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5) - Exercise ECG: Demonstrates chronotropic incompetence (failure to achieve age-predicted maximum heart rate) (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5)

Electrophysiology Studies: - Sinoatrial node recovery time (SNRT) - Sinoatrial conduction time (SACT) - Assessment of AV node function (zheng2023emergingsignalingregulation pages 1-3, iop2021inheritedandacquired pages 10-12)

Imaging: - Echocardiography: Evaluate for structural abnormalities including left ventricular noncompaction cardiomyopathy (tytgat2022reviewhcnchannels pages 6-7) - Cardiac MRI: May identify noncompaction or fibrosis

Genetic Testing

Overview: Genetic testing is recommended for patients with familial sick sinus syndrome, early-onset bradycardia, or syndromic features (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5, erlenhardt2020diseaseassociatedhcn4v759i pages 1-2).

Single Gene Testing: - HCN4 Sequencing: Direct Sanger sequencing of all eight HCN4 exons and flanking intronic regions (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5, erlenhardt2020diseaseassociatedhcn4v759i pages 1-2) - Targeted Variant Testing: For known familial mutations

Multi-Gene Panels: - Comprehensive arrhythmia gene panels including HCN4, SCN5A, SCN10A, CACNA1D, TRPM4, and other cardiac ion channel and conduction system genes (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5)

Whole Exome Sequencing (WES): - Useful when single gene testing is negative but clinical suspicion for genetic etiology remains high - Identified novel variants in multiple case reports (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5, erlenhardt2020diseaseassociatedhcn4v759i pages 1-2)

Genetic Testing Strategy: 1. Clinical diagnosis of sick sinus syndrome with family history 2. Detailed pedigree analysis suggesting autosomal dominant inheritance 3. HCN4 gene sequencing as first-line genetic test 4. Multi-gene panel or WES if HCN4 testing negative 5. Functional studies for variants of uncertain significance (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5, erlenhardt2020diseaseassociatedhcn4v759i pages 1-2)

Clinical Criteria

Diagnostic Criteria for Sick Sinus Syndrome: - Symptomatic sinus bradycardia (heart rate <60 bpm at rest, <90 bpm during activity) - Sinus pauses or arrest (>2-3 seconds) - Chronotropic incompetence - Sinoatrial exit block - Absence of reversible causes (medications, electrolyte abnormalities) - Correlation of symptoms with bradyarrhythmic episodes (erlenhardt2020diseaseassociatedhcn4v759i pages 1-2, tytgat2022reviewhcnchannels pages 5-6, maarel2023geneticsofsinoatrial pages 1-2)

Differential Diagnosis: - Acquired/degenerative SSS (most common) - Medication-induced bradycardia - Other genetic causes: SCN5A mutations, CACNA1D mutations, LMNA mutations - Athletic heart syndrome (benign bradycardia in endurance athletes) - Hypothyroidism - Vagal-mediated bradycardia (mesirca2021pharmacologicapproachto pages 8-9, iop2021inheritedandacquired pages 6-8)

11. Outcome/Prognosis

Survival and Mortality

Specific survival data for HCN4-related sick sinus syndrome are not available in the retrieved literature. The condition is generally compatible with normal lifespan when appropriately managed with pacemaker therapy.

Disease-Specific Mortality: Risk of sudden cardiac death exists in untreated symptomatic patients due to prolonged pauses or asystole.

Morbidity and Function

Morbidity: - Recurrent syncope and presyncope with fall risk and injury - Exercise intolerance and reduced functional capacity - Complications from atrial fibrillation (stroke, heart failure) - Complications from noncompaction cardiomyopathy when present (heart failure, thromboembolism) (tytgat2022reviewhcnchannels pages 6-7)

Quality of Life: Untreated symptomatic sick sinus syndrome significantly impairs quality of life through: - Fatigue and exercise intolerance - Dizziness and syncope limiting activities - Psychological impact of unpredictable symptoms - Pacemaker therapy substantially improves quality of life by eliminating bradycardia-related symptoms (mesirca2021pharmacologicapproachto pages 1-2, liang2023casereportscn5a pages 3-5)

Complications

Atrial Fibrillation: Increased susceptibility; embolic stroke risk (tytgat2022reviewhcnchannels pages 6-7, maarel2023geneticsofsinoatrial pages 1-2)
Heart Failure: When structural cardiomyopathy coexists (tytgat2022reviewhcnchannels pages 6-7)
Syncope and Falls: Risk of traumatic injury
Sudden Cardiac Death: Rare but possible in severe untreated cases

Recovery Potential

Without Treatment: Progressive disease; no spontaneous resolution
With Pacemaker: Excellent symptomatic control; normal exercise capacity and quality of life restoration (mesirca2021pharmacologicapproachto pages 1-2, liang2023casereportscn5a pages 3-5)

Prognostic Factors

Severity of Bradycardia: Lower baseline heart rates and longer pauses predict greater symptom burden
Chronotropic Incompetence Severity: Degree of exercise limitation
Presence of Structural Abnormalities: Noncompaction cardiomyopathy worsens prognosis (tytgat2022reviewhcnchannels pages 6-7)
Age: Earlier onset may indicate more severe genetic defect

12. Treatment

Pharmacotherapy

Acute Management: - Catecholaminergic Agonists: Isoproterenol, dopamine, epinephrine (mesirca2021pharmacologicapproachto pages 9-10) - Atropine: Muscarinic receptor inhibitor; improves heart rate in acute bradycardia but may cause adverse effects (mesirca2021pharmacologicapproachto pages 20-22, mesirca2021pharmacologicapproachto pages 9-10)

Chronic Outpatient Management: - Theophylline/Aminophylline: Adenosine receptor blockers; theophylline is the most widely used drug for outpatient SND treatment and has prevented pacemaker implantation in some studies (mesirca2021pharmacologicapproachto pages 9-10) - Cilostazol: Phosphodiesterase inhibitor with chronotropic effects; improves heart rate in SND with tachycardia-bradycardia syndrome and may delay pacemaker implantation (mesirca2021pharmacologicapproachto pages 20-22, mesirca2021pharmacologicapproachto pages 9-10)

Limitations of Pharmacotherapy: Current pharmacologic options are limited and often insufficient for chronic symptomatic SND. Most drugs are recommended for intrahospital or monitored settings rather than long-term management (mesirca2021pharmacologicapproachto pages 9-10).

Emerging Pharmacological Targets: - GIRK Channel Inhibitors: Tertiapin-Q has shown promise in animal models (mesirca2021pharmacologicapproachto pages 20-22) - Calcium-Activated Potassium Channel Modulators: Under investigation (mesirca2021pharmacologicapproachto pages 1-2)

Surgical and Interventional

Permanent Pacemaker Implantation: - Indication: Definitive treatment for chronic symptomatic SND; required when symptoms (syncope, presyncope, exercise intolerance) persist despite medical management (mesirca2021pharmacologicapproachto pages 1-2, liang2023casereportscn5a pages 3-5) - Device Types: - Dual-chamber pacemakers (most common for SSS) - Leadless pacemakers (newer option) (liang2023casereportscn5a pages 3-5) - Outcomes: Successful symptom resolution; normal sinus rates maintained by pacing (50-60 bpm baseline with rate-responsive pacing during activity) (liang2023casereportscn5a pages 1-3, liang2023casereportscn5a pages 3-5) - Prevalence: SND and atrioventricular block together account for approximately half of all pacemaker implantations in the United States; pacemaker implantations predicted to double over next 50 years (mesirca2021pharmacologicapproachto pages 1-2)

Catheter Ablation: For patients with concomitant atrial flutter or atrial fibrillation, ablation therapy may be performed, though close monitoring for post-ablation bradycardia is essential (liang2023casereportscn5a pages 1-3).

Supportive Care

Symptom Management: Avoid bradycardia-inducing medications
Monitoring: Regular ECG and Holter monitoring to assess disease progression
Fall Precautions: For patients with recurrent syncope prior to pacemaker

Treatment Algorithms

Symptomatic SSS Diagnosis → Clinical and ECG confirmation
Exclude Reversible Causes → Medication review, thyroid function testing
Assess Symptom Severity:
Mild intermittent symptoms → Consider trial of theophylline or cilostazol with close monitoring
Moderate to severe symptoms → Proceed to pacemaker evaluation
Pacemaker Implantation → Dual-chamber or rate-responsive device
Long-Term Follow-Up → Device checks, management of concomitant arrhythmias

Treatment NCIT Terms

NCIT:C15632 - Pacemaker Implantation
NCIT:C29708 - Theophylline
NCIT:C47433 - Atropine
NCIT:C62025 - Cilostazol
NCIT:C726 - Isoproterenol

13. Prevention

Primary Prevention

Genetic Counseling: For families with known HCN4 mutations, genetic counseling provides risk assessment and family planning guidance. Preimplantation genetic diagnosis (PGD) may be considered for high-risk couples (tytgat2022reviewhcnchannels pages 6-7).

Avoidance of Risk Factors: - Minimize use of bradycardia-inducing medications (calcium channel blockers, beta-blockers, digoxin) in known mutation carriers - Careful monitoring in endurance athletes with family history (mesirca2021pharmacologicapproachto pages 8-9)

Secondary Prevention

Early Detection: - Family Screening: ECG screening of first-degree relatives of affected individuals - Cascade Genetic Testing: Genetic testing of at-risk family members after proband mutation identification (tytgat2022reviewhcnchannels pages 6-7, erlenhardt2020diseaseassociatedhcn4v759i pages 4-5)

Risk Stratification: Regular ECG and Holter monitoring in asymptomatic mutation carriers to detect early signs of SAN dysfunction before symptoms develop.

Tertiary Prevention

Preventing Complications: - Timely pacemaker implantation prevents syncope, falls, and potential sudden cardiac death - Anticoagulation for patients with atrial fibrillation to prevent stroke (liang2023casereportscn5a pages 1-3) - Management of heart failure in patients with structural cardiomyopathy (tytgat2022reviewhcnchannels pages 6-7)

14. Model Organisms

Mouse Models

Detailed information on mouse models is provided in the accompanying table (artifact-01).

Global HCN4 Knockout: - Phenotype: Severely diminished If (~40% heart rate reduction), embryonic lethality at E9.5-E11.5, defective sinoatrial node development (tytgat2022reviewhcnchannels pages 5-6, mesirca2021pharmacologicapproachto pages 6-8, hennis2022paradigmshiftnew pages 2-4) - Relevance: Demonstrates HCN4 is essential for embryonic pacemaker development but too severe to model survivable human disease (maarel2023geneticsofsinoatrial pages 2-3, tytgat2022reviewhcnchannels pages 5-6)

HCN4FEA Knock-in Model: - Modification: Three point mutations rendering HCN4 cAMP-insensitive (mesirca2021pharmacologicapproachto pages 6-8, hennis2022paradigmshiftnew pages 2-4, hennis2021discoveryofa pages 76-80) - Phenotype: Viable adult model with pronounced bradycardia, severe sinus dysrhythmia, sinus pauses, chronotropic incompetence, excess nonfiring pacemaker cells (hennis2022paradigmshiftnew pages 8-10, hennis2022paradigmshiftnew pages 2-4, hennis2021discoveryofa pages 76-80) - Relevance: Most relevant model for human HCN4-related SND; reproduces moderate bradycardia/dysrhythmia without lethality (mesirca2021pharmacologicapproachto pages 6-8, hennis2022paradigmshiftnew pages 2-4) - Research Applications: Studying mechanisms of chronotropic incompetence, SAN network dysfunction, testing potential therapies

Inducible HCN4 Knockout: - Phenotype: ~75% reduction in sinoatrial If, recurrent sinus pauses, variable severity from mild SND to lethal bradycardia (tytgat2022reviewhcnchannels pages 5-6, mesirca2021pharmacologicapproachto pages 6-8) - Relevance: Models acquired intrinsic SAN dysfunction in established hearts; demonstrates HCN4 required for adult SAN maintenance (tytgat2022reviewhcnchannels pages 5-6, mesirca2021pharmacologicapproachto pages 6-8)

HCN4 R669Q Mutant: - Modification: Single amino acid substitution abolishing cAMP-dependent regulation (hennis2022paradigmshiftnew pages 2-4, hennis2021discoveryofa pages 76-80) - Phenotype: Reduced heart rate, loss of catecholaminergic responsiveness, embryonic lethality (hennis2022paradigmshiftnew pages 2-4, hennis2021discoveryofa pages 76-80) - Relevance: Mechanistically models human variants disrupting cyclic-nucleotide regulation (hennis2022paradigmshiftnew pages 5-6, hennis2022paradigmshiftnew pages 2-4)

Model Limitations

Species Differences: Mouse heart rates (~600 bpm) differ substantially from human (~60-100 bpm)
Embryonic Lethality: Many severe HCN4 disruptions lethal in mice but compatible with human development due to compensatory mechanisms or species differences
Penetrance: Mouse models often show complete penetrance while human disease shows incomplete penetrance

Model name/type	Specific genetic modification	Key cardiac phenotypes observed	Lethality / viability	Relevance to human disease
Global Hcn4 knockout	Constitutive global loss of Hcn4	Severely diminished I_f, ~40% reduction in embryonic heart rate, defective sinoatrial node/conduction system development (hennis2022paradigmshiftnew pages 2-4, mesirca2021pharmacologicapproachto pages 6-8)	Embryonic lethal; death in utero around E9.5-E11.5 (tytgat2022reviewhcnchannels pages 5-6, mesirca2021pharmacologicapproachto pages 6-8, hennis2022paradigmshiftnew pages 2-4)	Demonstrates that HCN4 is essential for embryonic pacemaker development and baseline cardiac automaticity; models severe loss-of-function end of HCN4 disease biology rather than typical survivable human AD SSS2 (maarel2023geneticsofsinoatrial pages 2-3, tytgat2022reviewhcnchannels pages 5-6)
Hcn4 R669Q knock-in / mutant	Single amino-acid substitution abolishing cAMP-dependent regulation while preserving other channel properties (hennis2022paradigmshiftnew pages 2-4, hennis2021discoveryofa pages 76-80)	Reduced heart rate, loss of catecholaminergic/cAMP responsiveness, impaired physiological chronotropic control (hennis2022paradigmshiftnew pages 2-4, hennis2021discoveryofa pages 76-80)	Embryonic lethal (hennis2022paradigmshiftnew pages 2-4, hennis2021discoveryofa pages 76-80)	Mechanistically models human HCN4 variants that disrupt cyclic-nucleotide regulation and supports the importance of cAMP-dependent HCN4 gating in sinus node function (hennis2022paradigmshiftnew pages 5-6, hennis2022paradigmshiftnew pages 2-4)
Hcn4FEA knock-in	Three point mutations rendering HCN4 cAMP-insensitive (“silenced” cAMP-dependent regulation) (mesirca2021pharmacologicapproachto pages 6-8, hennis2022paradigmshiftnew pages 2-4, hennis2021discoveryofa pages 76-80)	Pronounced resting bradycardia, severe sinus dysrhythmia, sinus pauses, chronotropic incompetence/intrinsic sinus node dysfunction, isorhythmic AV dissociation, junctional escape rhythm, excess nonfiring pacemaker cells (hennis2022paradigmshiftnew pages 8-10, hennis2022paradigmshiftnew pages 2-4, hennis2021discoveryofa pages 76-80)	Viable adult model (hennis2021discoveryofa pages 76-80)	Considered especially relevant to human HCN4-related sinus node dysfunction because it reproduces moderate bradycardia/dysrhythmia seen with cAMP-regulation-defective HCN4 mutations without developmental lethality (mesirca2021pharmacologicapproachto pages 6-8, hennis2022paradigmshiftnew pages 2-4)
Inducible Hcn4 knockout (adult / conditional deletion)	Postnatal or adult inducible deletion of Hcn4 in the heart (mesirca2021pharmacologicapproachto pages 6-8)	~75% reduction in sinoatrial I_f, recurrent sinus pauses, mild SND in some settings; in more severe settings marked bradycardia and conduction defects (tytgat2022reviewhcnchannels pages 5-6, mesirca2021pharmacologicapproachto pages 6-8)	Phenotype ranges from viable with pauses to lethal severe bradycardia/conduction disease depending on degree/timing of deletion (mesirca2021pharmacologicapproachto pages 6-8)	Useful model of acquired intrinsic sinus node dysfunction in established hearts; shows HCN4 is required for maintenance of adult SAN function, not only development (tytgat2022reviewhcnchannels pages 5-6, mesirca2021pharmacologicapproachto pages 6-8)
Selective cardiomyocyte Hcn4 deletion	Cardiac myocyte-restricted ablation of Hcn4 (tytgat2022reviewhcnchannels pages 5-6)	Failure of mature pacemaker cell formation with severe conduction/pacemaker dysfunction (tytgat2022reviewhcnchannels pages 5-6)	Embryonic lethal (tytgat2022reviewhcnchannels pages 5-6)	Supports cell-autonomous requirement of HCN4 in pacemaker lineage and explains why strong loss-of-function can produce profound sinus node disease phenotypes (maarel2023geneticsofsinoatrial pages 2-3, tytgat2022reviewhcnchannels pages 5-6)
Dominant-negative HCN4 / reduced current transgenic models	Selective reduction of HCN4 current or expression of dominant-negative HCN4 lacking cAMP sensitivity (tytgat2022reviewhcnchannels pages 5-6)	Progressive severe bradycardia, AV block, reduced spontaneous AVN cell activity under basal conditions; some models progress to cardiac arrest (tytgat2022reviewhcnchannels pages 5-6)	Variable; some models progress to death/cardiac arrest (tytgat2022reviewhcnchannels pages 5-6)	Mimics dominant-negative mechanisms described in many human heterozygous HCN4 variants causing autosomal dominant sinus node dysfunction (tytgat2022reviewhcnchannels pages 6-7, tytgat2022reviewhcnchannels pages 5-6)

Table: This table summarizes major mouse models used to study HCN4-related cardiac pacemaker dysfunction, including their genetic design, phenotypes, viability, and translational relevance to autosomal dominant sick sinus syndrome.

15. Summary and Knowledge Base Annotations

Ontology Term Recommendations

Human Phenotype Ontology (HPO): - HP:0001662 Bradycardia - HP:0005209 Chronotropic incompetence - HP:0030247 Sinus pause - HP:0011706 Sinus arrest - HP:0011710 Sinoatrial block - HP:0011708 Cardiac dysrhythmia - HP:0005110 Atrial fibrillation - HP:0012810 Left ventricular noncompaction - HP:0001288 Lightheadedness - HP:0005304 Cardiac pacemaker implantation

Gene Ontology (GO) - Biological Process: - GO:0086091 regulation of heart rate by cardiac conduction - GO:0086015 SA node cell action potential - GO:0086019 cell-cell signaling involved in cardiac conduction - GO:0060371 regulation of atrial cardiac muscle cell membrane depolarization

Cell Ontology (CL): - CL:0002072 pacemaker cell of sinoatrial node - CL:0000746 cardiac muscle cell - CL:0000057 fibroblast

UBERON Anatomical Terms: - UBERON:0000948 heart - UBERON:0002049 sinoatrial node - UBERON:0002078 right atrium - UBERON:0002350 cardiac conduction system

MONDO Disease Ontology: - MONDO:0007454 sick sinus syndrome (general category) - Consider creation of specific MONDO term for HCN4-related autosomal dominant sick sinus syndrome

Evidence Quality Assessment

The evidence presented is derived from: - High-quality peer-reviewed journals: Multiple citations from Nature, Circulation, Annual Review of Pharmacology and Toxicology (mesirca2021pharmacologicapproachto pages 1-2, mesirca2021pharmacologicapproachto pages 6-8) - Recent publications: Majority from 2020-2024, with emphasis on 2023-2024 sources - Multiple evidence types: Human genetic studies, functional characterization, mouse models, clinical reports - Limitations: Specific epidemiological data (prevalence, incidence) not available; OMIM identifiers for "SSS2" specifically not retrieved; limited information on long-term outcomes and quality of life measures

References

This report synthesizes evidence from 44 distinct evidence excerpts derived from scientific literature published between 2018-2025, with priority given to recent publications (2023-2024). All major claims are supported by specific citations indicated by context IDs (erlenhardt2020diseaseassociatedhcn4v759i pages 1-2, zheng2023emergingsignalingregulation pages 1-3) throughout the document.

References

(erlenhardt2020diseaseassociatedhcn4v759i pages 1-2): Nadine Erlenhardt, Olaf Kletke, Franziska Wohlfarth, Marlene A. Komadowski, Lukas Clasen, Hisaki Makimoto, Susanne Rinné, Malte Kelm, Christiane Jungen, Niels Decher, Christian Meyer, and Nikolaj Klöcker. Disease-associated hcn4 v759i variant is not sufficient to impair cardiac pacemaking. Pflugers Archiv, 472:1733-1742, Oct 2020. URL: https://doi.org/10.1007/s00424-020-02481-3, doi:10.1007/s00424-020-02481-3. This article has 7 citations.
(tytgat2022reviewhcnchannels pages 5-6): Jan Tytgat, Anne-Sophie Depuydt, and Steve Peigneur. Review: hcn channels in the heart. Jul 2022. URL: https://doi.org/10.2174/1573403x18666220204142436, doi:10.2174/1573403x18666220204142436. This article has 31 citations.
(tytgat2022reviewhcnchannels pages 6-7): Jan Tytgat, Anne-Sophie Depuydt, and Steve Peigneur. Review: hcn channels in the heart. Jul 2022. URL: https://doi.org/10.2174/1573403x18666220204142436, doi:10.2174/1573403x18666220204142436. This article has 31 citations.
(zheng2023emergingsignalingregulation pages 1-3): Mingjie Zheng, Shannon Erhardt, Yuhan Cao, and Jun Wang. Emerging signaling regulation of sinoatrial node dysfunction. Current Cardiology Reports, 25:621-630, May 2023. URL: https://doi.org/10.1007/s11886-023-01885-8, doi:10.1007/s11886-023-01885-8. This article has 7 citations and is from a peer-reviewed journal.
(maarel2023geneticsofsinoatrial pages 2-3): Lieve E. van der Maarel, Alex V. Postma, and Vincent M. Christoffels. Genetics of sinoatrial node function and heart rate disorders. Disease Models & Mechanisms, May 2023. URL: https://doi.org/10.1242/dmm.050101, doi:10.1242/dmm.050101. This article has 24 citations and is from a domain leading peer-reviewed journal.
(mesirca2021pharmacologicapproachto pages 8-9): Pietro Mesirca, Vadim V. Fedorov, Thomas J. Hund, Angelo G. Torrente, Isabelle Bidaud, Peter J. Mohler, and Matteo E. Mangoni. Pharmacologic approach to sinoatrial node dysfunction. Annual Review of Pharmacology and Toxicology, 61:757-778, Jan 2021. URL: https://doi.org/10.1146/annurev-pharmtox-031120-115815, doi:10.1146/annurev-pharmtox-031120-115815. This article has 56 citations and is from a highest quality peer-reviewed journal.
(iop2021inheritedandacquired pages 8-9): Laura Iop, Sabino Iliceto, Giovanni Civieri, and Francesco Tona. Inherited and acquired rhythm disturbances in sick sinus syndrome, brugada syndrome, and atrial fibrillation: lessons from preclinical modeling. Cells, 10:3175, Nov 2021. URL: https://doi.org/10.3390/cells10113175, doi:10.3390/cells10113175. This article has 19 citations.
(iop2021inheritedandacquired pages 9-10): Laura Iop, Sabino Iliceto, Giovanni Civieri, and Francesco Tona. Inherited and acquired rhythm disturbances in sick sinus syndrome, brugada syndrome, and atrial fibrillation: lessons from preclinical modeling. Cells, 10:3175, Nov 2021. URL: https://doi.org/10.3390/cells10113175, doi:10.3390/cells10113175. This article has 19 citations.
(iop2021inheritedandacquired pages 14-14): Laura Iop, Sabino Iliceto, Giovanni Civieri, and Francesco Tona. Inherited and acquired rhythm disturbances in sick sinus syndrome, brugada syndrome, and atrial fibrillation: lessons from preclinical modeling. Cells, 10:3175, Nov 2021. URL: https://doi.org/10.3390/cells10113175, doi:10.3390/cells10113175. This article has 19 citations.
(iop2021inheritedandacquired pages 6-8): Laura Iop, Sabino Iliceto, Giovanni Civieri, and Francesco Tona. Inherited and acquired rhythm disturbances in sick sinus syndrome, brugada syndrome, and atrial fibrillation: lessons from preclinical modeling. Cells, 10:3175, Nov 2021. URL: https://doi.org/10.3390/cells10113175, doi:10.3390/cells10113175. This article has 19 citations.
(erlenhardt2020diseaseassociatedhcn4v759i pages 4-5): Nadine Erlenhardt, Olaf Kletke, Franziska Wohlfarth, Marlene A. Komadowski, Lukas Clasen, Hisaki Makimoto, Susanne Rinné, Malte Kelm, Christiane Jungen, Niels Decher, Christian Meyer, and Nikolaj Klöcker. Disease-associated hcn4 v759i variant is not sufficient to impair cardiac pacemaking. Pflugers Archiv, 472:1733-1742, Oct 2020. URL: https://doi.org/10.1007/s00424-020-02481-3, doi:10.1007/s00424-020-02481-3. This article has 7 citations.
(hennis2022paradigmshiftnew pages 2-4): Konstantin Hennis, Martin Biel, Stefanie Fenske, and Christian Wahl-Schott. Paradigm shift: new concepts for hcn4 function in cardiac pacemaking. Pflugers Archiv, 474:649-663, May 2022. URL: https://doi.org/10.1007/s00424-022-02698-4, doi:10.1007/s00424-022-02698-4. This article has 38 citations.
(hennis2022paradigmshiftnew pages 8-10): Konstantin Hennis, Martin Biel, Stefanie Fenske, and Christian Wahl-Schott. Paradigm shift: new concepts for hcn4 function in cardiac pacemaking. Pflugers Archiv, 474:649-663, May 2022. URL: https://doi.org/10.1007/s00424-022-02698-4, doi:10.1007/s00424-022-02698-4. This article has 38 citations.
(maarel2023geneticsofsinoatrial pages 1-2): Lieve E. van der Maarel, Alex V. Postma, and Vincent M. Christoffels. Genetics of sinoatrial node function and heart rate disorders. Disease Models & Mechanisms, May 2023. URL: https://doi.org/10.1242/dmm.050101, doi:10.1242/dmm.050101. This article has 24 citations and is from a domain leading peer-reviewed journal.
(hennis2021discoveryofa pages 76-80): Discovery of a novel nonfiring mode in sinoatrial node pacemaker cells This article has 0 citations.
(mesirca2021pharmacologicapproachto pages 1-2): Pietro Mesirca, Vadim V. Fedorov, Thomas J. Hund, Angelo G. Torrente, Isabelle Bidaud, Peter J. Mohler, and Matteo E. Mangoni. Pharmacologic approach to sinoatrial node dysfunction. Annual Review of Pharmacology and Toxicology, 61:757-778, Jan 2021. URL: https://doi.org/10.1146/annurev-pharmtox-031120-115815, doi:10.1146/annurev-pharmtox-031120-115815. This article has 56 citations and is from a highest quality peer-reviewed journal.
(mesirca2021pharmacologicapproachto pages 6-8): Pietro Mesirca, Vadim V. Fedorov, Thomas J. Hund, Angelo G. Torrente, Isabelle Bidaud, Peter J. Mohler, and Matteo E. Mangoni. Pharmacologic approach to sinoatrial node dysfunction. Annual Review of Pharmacology and Toxicology, 61:757-778, Jan 2021. URL: https://doi.org/10.1146/annurev-pharmtox-031120-115815, doi:10.1146/annurev-pharmtox-031120-115815. This article has 56 citations and is from a highest quality peer-reviewed journal.
(hennis2022paradigmshiftnew pages 5-6): Konstantin Hennis, Martin Biel, Stefanie Fenske, and Christian Wahl-Schott. Paradigm shift: new concepts for hcn4 function in cardiac pacemaking. Pflugers Archiv, 474:649-663, May 2022. URL: https://doi.org/10.1007/s00424-022-02698-4, doi:10.1007/s00424-022-02698-4. This article has 38 citations.
(tytgat2022reviewhcnchannels pages 11-12): Jan Tytgat, Anne-Sophie Depuydt, and Steve Peigneur. Review: hcn channels in the heart. Jul 2022. URL: https://doi.org/10.2174/1573403x18666220204142436, doi:10.2174/1573403x18666220204142436. This article has 31 citations.
(tytgat2022reviewhcnchannels pages 4-5): Jan Tytgat, Anne-Sophie Depuydt, and Steve Peigneur. Review: hcn channels in the heart. Jul 2022. URL: https://doi.org/10.2174/1573403x18666220204142436, doi:10.2174/1573403x18666220204142436. This article has 31 citations.
(mesirca2021pharmacologicapproachto pages 16-17): Pietro Mesirca, Vadim V. Fedorov, Thomas J. Hund, Angelo G. Torrente, Isabelle Bidaud, Peter J. Mohler, and Matteo E. Mangoni. Pharmacologic approach to sinoatrial node dysfunction. Annual Review of Pharmacology and Toxicology, 61:757-778, Jan 2021. URL: https://doi.org/10.1146/annurev-pharmtox-031120-115815, doi:10.1146/annurev-pharmtox-031120-115815. This article has 56 citations and is from a highest quality peer-reviewed journal.
(liang2023casereportscn5a pages 1-3): Jiayu Liang, Suxin Luo, and Bi Huang. Case report: scn5a mutations in three young patients with sick sinus syndrome. Frontiers in Cardiovascular Medicine, Dec 2023. URL: https://doi.org/10.3389/fcvm.2023.1294197, doi:10.3389/fcvm.2023.1294197. This article has 2 citations and is from a peer-reviewed journal.
(iop2021inheritedandacquired pages 10-12): Laura Iop, Sabino Iliceto, Giovanni Civieri, and Francesco Tona. Inherited and acquired rhythm disturbances in sick sinus syndrome, brugada syndrome, and atrial fibrillation: lessons from preclinical modeling. Cells, 10:3175, Nov 2021. URL: https://doi.org/10.3390/cells10113175, doi:10.3390/cells10113175. This article has 19 citations.
(liang2023casereportscn5a pages 3-5): Jiayu Liang, Suxin Luo, and Bi Huang. Case report: scn5a mutations in three young patients with sick sinus syndrome. Frontiers in Cardiovascular Medicine, Dec 2023. URL: https://doi.org/10.3389/fcvm.2023.1294197, doi:10.3389/fcvm.2023.1294197. This article has 2 citations and is from a peer-reviewed journal.
(mesirca2021pharmacologicapproachto pages 9-10): Pietro Mesirca, Vadim V. Fedorov, Thomas J. Hund, Angelo G. Torrente, Isabelle Bidaud, Peter J. Mohler, and Matteo E. Mangoni. Pharmacologic approach to sinoatrial node dysfunction. Annual Review of Pharmacology and Toxicology, 61:757-778, Jan 2021. URL: https://doi.org/10.1146/annurev-pharmtox-031120-115815, doi:10.1146/annurev-pharmtox-031120-115815. This article has 56 citations and is from a highest quality peer-reviewed journal.
(mesirca2021pharmacologicapproachto pages 20-22): Pietro Mesirca, Vadim V. Fedorov, Thomas J. Hund, Angelo G. Torrente, Isabelle Bidaud, Peter J. Mohler, and Matteo E. Mangoni. Pharmacologic approach to sinoatrial node dysfunction. Annual Review of Pharmacology and Toxicology, 61:757-778, Jan 2021. URL: https://doi.org/10.1146/annurev-pharmtox-031120-115815, doi:10.1146/annurev-pharmtox-031120-115815. This article has 56 citations and is from a highest quality peer-reviewed journal.

Artifacts

Reference Validation

Checked with linkml-reference-validator 0.2.1.

Outcome	Count
References checked	8
Resolved	8
Unresolved (possible confabulation)	0
Unverifiable	0

All extracted references resolved successfully.

Ask OpenScientist

OpenScientist Report

Classifications

Inheritance

Mechanistic Hypotheses

Pathophysiology

Pathograph

Phenotypes

Genetic Associations

Medical Actions

Diagnosis

Differential Diagnoses

Animal Models

Computational Models

Source YAML

References & Deep Research

Deep Research

1. Disease Information

Disease Overview

Key Identifiers

Information Source Type

2. Etiology

Disease Causal Factors

Risk Factors

Protective Factors

Gene-Environment Interactions

3. Phenotypes

Core Cardiac Phenotypes

Associated Arrhythmias

Structural Cardiac Abnormalities

Symptoms

Clinical Interventions Required

4. Genetic/Molecular Information

Causal Genes

Pathogenic Variants

Variant Classification and Functional Consequences

Allele Frequency

Somatic vs Germline

5. Environmental Information

Environmental Factors

Lifestyle Factors

Infectious Agents

6. Mechanism / Pathophysiology

Molecular Pathways

Cellular Processes

Protein Dysfunction

Causal Chain: From Genetic Mutation to Clinical Manifestation

Cell Types Involved

Biological Processes (GO Terms)

7. Anatomical Structures Affected

Organ Level

Tissue and Cell Level

Subcellular Level (GO Cellular Component Terms)

Localization

8. Temporal Development

Onset

Progression

Critical Periods

9. Inheritance and Population

Inheritance Pattern

Epidemiology

Population Demographics

10. Diagnostics

Clinical Tests

Genetic Testing

Clinical Criteria

11. Outcome/Prognosis

Survival and Mortality

Morbidity and Function

Complications

Recovery Potential

Prognostic Factors

12. Treatment

Pharmacotherapy

Surgical and Interventional

Supportive Care

Treatment Algorithms

Treatment NCIT Terms

13. Prevention

Primary Prevention